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Abstract 
 
 
Neurons comprise the main information processing cells of the nervous 
system.  To integrate and transmit information, neurons elaborate dendritic 
structures to receive input and axons to relay that information to other cells.  Due 
to their intricate structures, dendrites and axons are susceptible to damage 
whether by physical means or via disease mechanisms.  Studying responses to 
axon injury, called Wallerian degeneration, in the neuronal processes of 
Drosophila melanogaster has allowed the identification of genes that are required 
for injury responses.  Screens in Drosophila have identified dsarm and highwire 
as two genes required for axon degeneration; when these genes are mutated 
axons fail to degenerate after injury, even when completely cut off from the 
neuronal cell body.  We found that these genes are also required for dendrite 
degeneration after injury in vivo.  Further, we reveal differences between axon 
and dendrite injury responses using in vivo timelapse recordings and GCaMP 
indicators of intracellular and mitochondrial calcium transients.  These data 
provide insights into the neuronal responses to injury, and better define novel 
targets for the treatment of neurodegenerative diseases. 
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Chapter I: Introduction 
 
The Nervous System 
The nervous system is our means of interacting with our environment.  It 
provides information about our surroundings and ourselves, from the feeling of 
thirst to the heat of a candle flame, and allows us to integrate that information 
and act appropriately and even automatically, from pouring a glass of water to 
jerking a finger away from the candle.  Sensory input travels through the 
peripheral nervous system (PNS) in nerves to the central nervous system (CNS), 
where it is processed and integrated into behavior that is enacted by motor 
output from the CNS to the muscles of the body.  All of this information transfer 
and computation occurs in the huge number of neurons and glia that make up 
the nervous system.  The diversity and complexity of tasks performed by these 
cells is made possible by virtue of their numbers as well as the great variety of 
different kinds of neurons and glia.     
Neurons are the cellular functional units that underlie our every sensation, 
thought, and action.  To perform such tasks, they form networks of connections 
with many other neurons and other cells to relay information and compute 
outcomes.  Importantly, they form these connections with two main structures: 
axons and dendrites.  Axons are long, slender structures that transmit signals to 
other cells while dendrites are branched structures (“dendron” is the Greek word 
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for tree) that receive and integrate those signals.  Both structures can exhibit 
extremely varied and often elaborate forms, some reaching as far as a meter 
from the cell body.  There is a relationship between axonal and especially 
dendritic structure and the function they impart to neurons.  For example, a 
neuron with a large, complex dendritic arbor with many branches can make 
connections with many other neurons and integrate their input signals to a single 
output through the axon.  Some sensory neurons, such as those that sense 
chemicals in the environment, have a rather simple, diminutive dendrite as their 
function is simply to respond to the presence of the chemical: no integration 
required. 
 
Dendrites vs. Axons 
Dendrites spatially and temporally integrate various sensory and synaptic 
signals by virtue of their structure, which varies between classes of neurons.  In 
fact, neurons are often classed based on the branching pattern of their 
dendrites1.  Similar to the look of tree branches, dendritic arbors consist of 
processes that ramify starting proximally near the cell body.  The most proximal 
segment of the dendrite is the largest in caliber, and with successive branching 
and distance from the soma the dendrites taper in size2.  Axons are largely 
uniform in caliber and only branch at the termini in synaptic areas.  Organelle and 
molecular components also distinguish axons and dendrites.  Nearly all cellular 
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organelles can be found in dendrites, including mitochondria, rough endoplasmic 
reticulum, Golgi bodies, and polyribosomes.  This is in contrast with axons, which 
typically only contain mitochondria and not rough endoplasmic reticulum, Golgi 
bodies, or polyribosomes3,4,5.  Cytoskeletal polarity is another distinguishing 
feature between these two compartments.  Microtubules are polymeric cylinders 
that provide rigid structural support and have identifiable ends due to the 
arrangement of their α and β subunits; these are denoted the plus and minus 
ends6.  Axonal microtubules are aligned plus end towards the synapse and 
minus end towards the cell body.  In dendrites, the microtubules are arranged in 
both directions7,8.  These arrangements have implications for the transport of 
proteins and other cellular components as the motor proteins responsible for 
transport either move towards microtubule plus ends or the minus ends9.  
Additionally, some cytoskeletal binding proteins are only found in axons 
(unphosphorylated tau) or dendrites (MAP2)10,11. 
Another difference between the two structures is the manner in which 
axons and dendrites relay information.  This is due to the differential expression 
of ion channel in dendrites and axons.  Synaptic or sensory input to dendrites 
results in the opening of calcium channels, causing a net influx of calcium ions 
into the arbor12,13.  When sufficiently large, this calcium influx activates voltage-
gated channels and creates a sodium and calcium-based action potential that is 
then transmitted towards the axon often through the cell body.  At the most 
proximal part of the axon, this action potential activates voltage-gated sodium 
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channels and converts the signal into the predominantly sodium-based axonal 
action potential14.  This difference in signal propagation also requires different 
mechanisms to regulate ion levels during and after activation.  For example, 
calcium does not play a major role in the axonal action potential, and intra-axonal 
levels do not normally vary to the degree seen in dendrites15.  In axons, calcium 
levels are maintained by the plasma membrane sodium/calcium exchanger and 
via the uptake by mitochondria16.  Dendrites utilize a plasma membrane ATPase 
fueled by glycolysis to rapidly and actively return dendroplasmic calcium to 
resting levels17,18.  Thus, many factors differ between axons and dendrites 
relating to the specialization and function of these structures. 
 
The Drosophila Nervous System 
 The fruit fly Drosophila melanogaster is the first established model 
organism, and has been used in biological research for over 100 years.  The 
ease of maintenance, genetic tractability, and plethora of genetic tools has led to 
many seminal discoveries in various fields.  The Drosophila nervous system 
shows remarkable conservation with the mammalian nervous system.  Flies 
sense, move within, and interact with their environment, integrating sensory 
information and displaying complex behaviors such as learning – all aspects of 
complex nervous system function.  Indeed, the basic principles of nervous 
system function are identical between flies and you.   Accordingly, the fly nervous 
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system contains similar cell types as mammals, including subtypes of neurons 
and glia that physically resemble and function as do their mammalian 
counterparts19.  Thus, Drosophila provides an excellent model to study nervous 
system biology in vivo. 
 
Nervous System Dysfunction and Injury 
 The nervous system is a vital and complex system that regulates most 
aspects of animal life.  It is also susceptible to injury and disease, which causes 
significant pathology and suffering.  Diseases may affect specific components, 
such as motor neurons in amyotrophic lateral sclerosis (ALS), or dopaminergic 
neurons in Parkinson’s disease20,21.  Less discriminant injuries occur due to 
trauma, diabetic neuropathy, and from increased intracranial pressure as found 
in metastatic cancer and intracranial bleeding.  Axons and dendrites can also be 
differentially affected.  For example, motor neuron disease such as gracile axonal 
dystrophy often leads to the dying back of axonal processes22.  Similarly, 
dendrites can specifically degenerate due to Aβ plaques in Alzheimer’s disease 
or excitotoxicity following hypoxia/ischemia in stroke23,24.   
Axons and dendrites are equally vulnerable to physical injury, such as 
from trauma.  When injured, they stereotypically fall apart and the remains are 
then cleared by surrounding cells within a couple of days.  This process was first 
described over 165 years ago in frog hypoglossal axons by Augustus Waller25.  
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The eponymous process of Wallerian degeneration (WD) appeared to be due to 
the axon being separated from its lifeline the cell body.  Wallerian degeneration is 
classically studied in response to physical transection of axonal processes.  
Whether in culture or in vivo, the distal part of the axon is immediately cut off 
from the cell body.  This distal stump remains unchanged for several hours to a 
day or so (35-44hrs in mouse sciatic nerve), depending on the neuron type and 
model used.  The entire distal stump then undergoes a rapid, catastrophic 
granular disintegration, leaving only fragmented axonal debris25.  Surrounding 
glial cells or other phagocytes then clear the debris.  If not cleared appropriately, 
this debris can hinder the axon regeneration that often occurs in the peripheral 
nervous system26. 
For 140 years, WD was assumed to be a passive degenerative response 
of the distal axonal stump to being cut off from the cell body.  This assumption 
predominated until the fortuitous discovery of a mouse whose axons failed to 
degenerate after transection, and instead remained intact for weeks rather than a 
day27.  Later called the Wlds mouse (for slow Wallerian degeneration), its 
discovery transformed the way we think about WD: from a passive wasting away 
to an active process that could be prevented. 
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Slow Wallerian Degeneration 
WLDs arose from a spontaneous tandem triplication event that resulted in 
the fusion of the full coding sequence of Nmnat1, a rate-limiting enzyme in an 
NAD+ salvage pathway, and the first 70 amino acids of Ube4b, an E4 ubiquitin 
ligase, leaving the endogenous loci of Nmnat1 and Ube4b intact28–30.  While the 
short sequence derived from Ube4b is unlikely to have ligase activity, NMNAT1 
enzymatic activity is preserved; indeed it is required for the protection of axons31.  
How does this mutant protein protect injured axons?  Two hypotheses dominate 
the field.  First, WLDs may substitute for an axonal survival factor that is 
degraded after injury and the loss of which causes degeneration.  Second, WLDs 
may alter axon biology in such a way as to prevent a signal caused by axotomy 
from enacting the degeneration program.  Note that these hypotheses are not 
necessarily mutually exclusive. 
In the first case, there is evidence that WLDs takes the place of 
endogenous NMNAT proteins, which act as a critical signal for axon integrity.  
This idea stems from the trophic factor theory: the soma continuously supplies a 
vital factor that becomes depleted in the distal stump after axotomy due to it 
being cut off from the cell body32.  NMNAT2 is a good candidate for this factor as 
it is an extremely labile protein that is transported in axons, levels decrease 
sharply upon axotomy, and when depleted in neurons causes degeneration that 
is suppressed by WLDs33,34.  Additionally, WLDs can rescue the postnatal lethality 
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and axon outgrowth defects of Nmnat2-/- mice33.  NMNAT2, then, may indeed act 
as an axonal trophic factor required to stave off WD. 
The second hypothesis invokes a gain-of-function role for the protein.  
WLDs requires enzymatic activity to protect axons31,35–38, however, no consistent 
link between NAD+ and WD has been shown39.  There is no increase in basal 
NAD+ with WLDs30,36, and addition of NAD+ to axons has shown slight protection 
in some studies but not others36,37,40–42.  Other studies have highlighted the role 
of mitochondria in axon degeneration43.  Additionally, a mitochondrial localization 
for WLDs has been observed and also correlated with increased ATP production 
and calcium buffering capacity35,44.  Indeed, a drop in ATP precedes 
degeneration after axotomy45.  WLDs could, therefore, enhance mitochondrial 
function to maintain axonal homeostasis after injury thereby preventing WD. 
The influx of extracellular calcium is both necessary and sufficient for WD 
in vitro and in vivo46.  Several studies have shown that blocking L-type calcium 
channels or chelating extracellular calcium prevents the intra-axonal 
accumulation of calcium and the fragmentation of the injured axons46,47.  Calcium 
is thought to activate the calcium-dependent protease calpain, leading to the 
breakdown of cytoskeletal and axonal proteins.  Inhibition by endogenous murine 
calpastatin in vitro and in vivo can modulate WD48.  Interestingly, WLDs may 
prevent WD by enhanced calcium buffering by mitochondria, and was shown to 
attenuate a calcium spike upon laser ablation of Drosophila larval motor 
neurons44.  Together with a mitochondrial localization for WLDs, as well as 
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increased mitochondrial ATP production35,44, these results suggest that WLDs 
could operate in or on mitochondria to prevent WD. 
The fragment of Ube4b found in WLDs is known to interact with the 
valosin-containing protein (VCP)31, an ATPase involved in the ubiquitin-
proteasome system, which is also found in mitochondria49.  VCP is thought to 
redistribute WLDs from the normally nuclear localization of NMNAT1, including 
potentially to mitochondria50.  Interestingly, both Nmnat1 and VCP are hexamers, 
and the interaction of WLDs with VCP may preserve the enzymatically competent 
structure of NMNAT151,52.  Critically, WLDs requires its enzymatic activity as well 
as VCP binding to prevent WD, suggesting that this may be the case31. 
Though apoptosis and WD are both active cell death processes, they are 
distinct.  Caspase activation is not observed in WD, but is required for 
apoptosis53.  Likewise, neither Bax deletion nor BCL-2 overexpression alters WD 
while both manipulations inhibit apoptosis54,55.  Additionally, WLDs expression 
does not affect the apoptosis in motor neuron cell bodies after axotomy56.  
Developmental neurite degeneration, or pruning, is also distinct from WD.  In 
Drosophila sensory neuron pruning, knock down of several genes gives pruning 
defects in dendrites but does not affect degeneration of these same dendrites 
after laser ablation.  The genes include: dronc, Mical, Kat-60L, and IK257.  
Additionally, WLDs expression did not alter the developmental pruning of mouse 
cortical and retinal axons nor fly mushroom body axons, yet protected these 
axons from injury58.  Together, these results provide strong support that 
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developmental and injury-induced degeneration operate through distinct 
mechanisms. 
Given the robust protection of severed axons by WLDs, there has been 
much interest in testing whether there is also neuronal protection in models of 
neurodegeneration.  Some such studies showed little or no protection by 
expression of WLDs.  These mostly include very strong models of motor neuron 
disease, such as several mutant SOD1 models of ALS where mutant SOD1 
proteins are overexpressed over long periods of time (months)59,60.  Several 
acute injury models, on the other hand, showed relatively strong protection by 
WLDs.  Toxic neuropathy induced by taxol treatment delayed axonal 
degeneration and improved mouse rotarod performance, a measure of motor 
coordination61.  In acute models of Parkinson’s disease, degeneration was 
delayed after administration of 6-hydroxydopamine as well as MPTP, which both 
lead to dopaminergic cell death62–64.  In a mouse model of hypoxia/ischemia, 
delayed degeneration was shown up to 1 week after carotid artery ligature65.  As 
a last example, NMDA injection into the retina results in excitotoxic injury, and 
WLDs delayed degeneration of retinal ganglion cells for greater than 2 weeks66.  
These studies show the promise of inhibiting WD in the treatment of 
neurodegenerative diseases, particularly in acute settings. 
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Drosophila Models of Wallerian Degeneration 
The first Drosophila system used to study WD was the olfactory receptor 
neuron model (ORN)67.  ORNs are chemosensory neurons that reside in the 
antennae of flies and project into the brain to synapse on spatially distinct 
glomeruli.  MacDonald, et al showed that removal of the antennae severs the 
olfactory nerve, leading to WD in the ORN axons, and that this degeneration is 
prevented by the expression of WLDs.  Distinct subsets of ORNs can be labelled 
using promotor-Gal4 constructs, such as the OR22a-Gal4 that drives expression 
in ~24 neurons in each antenna67.  ORN clones can be induced by using 
eyeless-flp (ey-flp), which generates flippase activity early in eye and antennal 
development.  The mosaic analysis with a repressible cell marker technique 
together with eyeless-flp can be used to create and specifically label 
homozygous mutant ORN clones in an otherwise heterozygous animal.  The 
ORN model has been extensively used to characterize WD and identify genetic 
components of the responses involved68.  For example, the initial structure-
function studies of WLDs were performed in ORNs31.  These studies showed that 
VCP binding and enzymatic activity are crucial to the protection shown by WLDs.  
Several studies investigating the glial response to axon injury identified the cell 
corpse receptor Draper and downstream signaling pathways as being critical for 
the recognition and engulfment of axonal debris19,69–71. 
Another model of WD in Drosophila that is especially useful for 
investigating dendritic biology centers on larval multidendritic sensory neurons.  
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These dendritic arborization (da) neurons tile the larval body wall providing 
sensory input for each segment of the larvae72.  They are classed I-IV according 
to the size of their receptive fields as well as the complexity of their dendritic 
arbors, class IV being the largest and most complex1.  Class III da neurons 
project several long primary dendrites that contain microtubules73.  Found along 
the length of these primary dendrites are projections called sensory 
filopodia/spikes, which are much shorter, highly dynamic, and rich in F-actin.  
The actin-based protrusion and retraction of the spikes, along with a complement 
of ion channels, is required in these cells for behavioral responses to light 
touch73. 
Class IV da neurons have the largest and most highly branched dendritic 
structures of the multidendritic sensory neurons1.  Their arbors tile the larval body 
wall, covering each larval body segment with little overlap between neighboring 
cells.  These cells have been shown to respond to many noxious stimuli such as 
touch, heat, and light (especially UV light)74–76.  Recently, the class IV da neurons 
were found to degenerate in a manner similar to axons after injury57.  Further, 
this degeneration was prevented by WLDs, suggesting that axons and dendrites 
share the mechanism and/or signaling that leads to degeneration.  After injury, 
the fragmented dendrites are engulfed by the overlying epithelium, which, similar 
to glia, utilize the engulfment receptor Draper77.  The class IV da neurons are 
also able to regenerate both axons and dendrites after injury, sprouting new 
branches from the cell bodies or the injured proximal stump78.  In contrast, class 
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III neurons do not regenerate axons or dendrites from injured branches78, but are 
able to sprout new branches from the cell body after ablation of all dendritic 
branches early in larval life79.  Thus, there appears to be a differential response 
to injury between class III and class IV da neurons. 
 
dSarm/SARM1 
An unbiased forward-genetic screen in the ORNs identified the first 
endogenous regulator of WD with protection that rivaled WLDs, dsarm68.  dsarm 
and the mouse ortholog Sarm1 are members of the Myd88 family of 
Toll/interleukin-1 receptor (TIR) domain containing immune signaling proteins80.   
TIR domains relay signals from Toll receptors to downstream signaling pathways 
such as the NFκB pathway80.  Sarm proteins also contain Armadillo (ARM) 
repeats and a number of sterile alpha motif (SAM) domains, both of which 
mediate protein-protein interactions81.  Sarm proteins are very conserved across 
phyla; C. elegans tir-1 and Drosophila dsarm share 40% identity with human 
Sarm181. 
In C. elegans, TIR-1 acts within a pathway downstream of calcium and the 
calcium/calmodulin-dependent kinase CaMK and upstream of the ASK-1 MAP 
kinase kinase kinase in the differentiation of a pair of ORNs, as well as in the 
behavioral adaptation to odors82–84.  Interestingly, expression of TIR-1 lacking the 
ARM domain showed a gain-of-function phenotype in the ORNs, suggesting that 
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the ARM domain acts to inhibit TIR-1 signaling82.  Mouse studies of SARM1 have 
largely been conducted in immune assays with overexpression of the protein, 
which indicate a negative role for SARM1 in innate immune signaling.  This 
regulation stems from a transcriptional regulation of another TIR domain 
containing adapter protein, TIR-domain-containing adapter-inducing interferon-β 
(TRIF)85,86.  Whether Sarm proteins also regulate WD via transcriptional changes 
remains to be determined. 
A structure-function study of SARM1 has been conducted in mouse dorsal 
root ganglia culture (DRG)87.  This study concluded that all three domains of 
SARM1 are required for proper axon degeneration.  It also showed that SARM1 
proteins dimerize via the SAM domains, and that the TIR domain is required for 
downstream signaling as expression of SARM1 lacking the TIR domain acted as 
a dominant negative, blocking axon degeneration.  Similar to the worm data, 
elimination of the ARM domain in SARM1 created a dominant active version that 
induced the destruction of axons and cell bodies.  Additionally, GFP-tagged 
SARM1 was found have a mitochondrial localization, suggesting that SARM1 
could, like WLDs, work in or on mitochondria. 
A recent study placed SARM1 upstream of a MAP kinase cascade that 
ultimately led to c-Jun N-terminal kinase (JNK) activation and ATP depletion in 
severed axons45.  The pathway consists of SARM1 activating MEKK4/MLK2/DLK 
that then activate MKK4/MKK7 that then activate JNK1/2/3.  A Jnk1/Jnk2 double 
knock-out with shRNA knock-down of JNK1 afforded protection to 60% of axons 
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at day 6 in vivo; the same level of protection has been shown at 2 weeks in 
Sarm1-/- axons. 
 
Hiw/PHR1 
 Recently, a second endogenous regulator of WD was discovered.  
Mutations in the gene encoding the Drosophila E3 ubiquitin ligase Highwire (Hiw) 
were shown to protect ORN axons up to 2 weeks after ablation and larval motor 
neurons for at least 2 days after crush, during which they remained electrically 
competent88.  It was later shown that the mouse ortholog, Phr1, also robustly 
regulates axon degeneration89.  The protection seen in PHR1-deficient axons, 
while strong (75% at day 5, 25% at day 10), is less than seen with WLDs or 
Sarm1 mutants (60% ablated axons preserved in mouse sciatic nerve at day 6)68.  
Hiw is a rather large protein (~5233 amino acids), and is well conserved across 
phyla; the C. elegans ortholog RPM-1 has 32% identity and 55% similarity to the 
human ortholog90.  It contains several domains implicated in signaling, protein 
interactions/scaffolding, and ubiquitin ligase activity; these include a RCC1-like 
domain, PHR repeats, a Myc-binding domain, and a RING-H2 zinc finger motif90.  
PHR family proteins are involved in many neuronal processes such as axon 
outgrowth, synaptogenesis, and regeneration of injured axons91. 
 In C. elegans, the E3 ubiquitin ligase activity of RPM-1 regulates several 
neuronal cell processes including restraining synapse formation during 
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development92.  It also has roles in negatively regulating axon regeneration, as 
rpm-1 mutants have enhanced regeneration via disinhibition of the MAPKKK 
DLK-193.  Additionally, RPM-1 is thought to regulate receptor trafficking via 
endocytosis.  Increased MAPK signaling in rpm-1 mutants results in the 
accumulation of AMPA receptors in the dendrites of interneurons94. 
 In addition to participating in axon degeneration in Drosophila, hiw 
mutants were originally found in a screen for perturbations at the larval 
neuromuscular junction (NMJ).  hiw mutants cause a pronounced overgrowth of 
NMJs, which has been linked with increased levels of BMP and DLK/MAPK 
signaling90,95. 
 In mice, axon guidance and synaptic development have also been linked 
to PHR1 E3 ligase activity in the Magellan mutant mouse96.  These phenotypes, 
similar to their invertebrate counterparts, are thought to be due to increased 
levels/activity of DLK as well as increases in signaling by the tuberous sclerosis 
complex via up regulation of TSC297.  Aberrant microtubule dynamics have also 
been observed in Magellan mice; microtubules inappropriately invade axon 
growth cones, thereby linking overgrowth phenotypes with cytoskeletal 
dysregulation96. 
 In the context of Wallerian degeneration, it is thought that Hiw/PHR1 E3 
ubiquitin ligase activity regulates the levels of NMNAT proteins, and causes their 
rapid loss after axotomy.  Accordingly, in hiw mutants, dNmnat levels become 
17 
 
detectable via immunostaining of larval peripheral nerves, and there are higher 
levels of exogenously expressed NMNAT288.  Increased levels of a transduced 
tagged NMNAT2 are also seen in Phr1 mutant nerves, while shRNA knock down 
of NMNAT2 suppresses the axon protection phenotype of Phr1 mutant animals89.  
While these results are consistent with the regulation of NMNAT proteins after 
axotomy, the regulation of endogenous NMNAT levels by Hiw family members 
has not been shown in this context. 
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Chapter II: Screens to Identify Novel Regulators of 
Wallerian Degeneration 
 
Introduction 
Without the discovery of the Wlds mouse, we may not have considered the 
notion that axons actively degenerate following injury.  The subsequent sea 
change in thinking about and interest in Wallerian degeneration (WD) led to 
many new and interesting findings.  For example, we have learned that axon 
degeneration in response to injury is molecularly distinct from other cell death 
pathways, such as developmental neurite pruning and apoptosis.  This fact along 
with the gain-of-function nature of Wlds necessitates the identification of 
endogenous regulators of axon degeneration if we are to fully understand this 
process.  Many genes have been implicated in regulating WD, however the 
reported preservation is much weaker than seen with Wlds39.  Therefore, new 
efforts to find WD genes are needed. 
Wallerian degeneration in mammals encompasses the processes of axon 
degeneration as well as the clearance of axonal debris by phagocytic cells, such 
as macrophages in the PNS and surrounding glia in the PNS and CNS.  
Drosophila olfactory receptor neurons (ORNs) have also been shown to 
degenerate after axotomy, which is prevented by the heterologous expression of 
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Wlds67.  Additionally, glia were shown to be activated by axotomy and to engulf 
the degenerated axon debris.  Thus, the processes of WD are well conserved 
between mammals and flies.  
Drosophila as a model organism has a long history of identifying roles for 
genes through genetic screens.  The ease of establishing and maintaining 
mutant stocks along with the ability to readily screen for phenotypes allows for 
rapid, large-scale screening in vivo.  We therefore sought to combine these 
attributes with the conservation of WD to identify endogenous genes required for 
WD.  These efforts ultimately lead to the identification of dsarm mutants as the 
first to prevent axon degeneration to a similar extent as Wlds68. 
The screen for novel regulators of WD is based on the axotomy and 
imaging of a subset of ORNs, which reside in the 3rd segment of the fly antennae 
and project their axons into the brain to synapse on the olfactory glomeruli.  
Axotomy is performed by removing the antennal 3rd segment, completely 
removing the cell bodies.  The brains and labelled ORN axons can then be 
antibody stained and imaged to assay WD.  Additionally, mutations that prevent 
viability in adult flies can be assayed using Mosaic Analysis with a Repressible 
Cell Marker (MARCM)98.  This technique produces and specifically labels cells 
homozygous for a particular chromosomal arm in an otherwise heterozygous 
animal.  This technique was used in the screen that identified dsarm, which 
screened approximately 1911 lines on both arms of chromosome 3, and 
identified 4 independent alleles of dsarm.  I therefore decided to develop the fly 
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stocks to screen both arms of the 2nd chromosome as well as take a candidate-
based approach to finding genes that regulate WD. 
In this study, I identified candidate genes from the literature and tested 
available mutants in the WD assay.  I also identified and tested mutants in WD 
assays based on mouse orthologs of genes identified by our collaborators.  
Finally, I developed fly stocks to perform a forward-genetic screen for WD 
mutants, tested several deletion stocks using these lines, constructed 1100 
individual mutants fly stocks, and together with Nicki Fox, PhD and later Rachel 
Hackett, screened the vast majority of these lines in the search for genes that 
regulate WD.  Herein I describe 199 mutant genotypes, 22 mapped deletions, 
and over 2000 mutant chromosome arms that are not required for axon 
degeneration in vivo.    
 
Candidates Identified in the Literature 
Materials and Methods 
The following fly strains were used to balance the lines tested as well as to 
cross in the ORN Gal4 driver along with the membrane marker mCD8::GFP:  
SP/CyO ; OR22a-Gal4, UAS-mCD8::GFP,  OR22a-Gal4, UAS-mCD8::GFP ; 
Dr/TM3, and  OR22a-Gal4, UAS-mCD8::GFP (II). Stocks with aberrations on the 
X chromosome were crossed to Or22a-Gal4, UAS-mCD8::GFP flies and males 
were used for the degeneration screen. Stocks for mutations on the second 
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chromosome were crossed to Sp/Cyo; OR22a-Gal4, UAS-mCD8::GFP, and the 
progeny were self-crossed to obtain homozygous mutant flies on the second and 
OR22a-Gal4, UAS-mCD8::GFP on the third chromosome, or crossed to the 
progeny of a similar cross with another allele of the same gene to obtain trans-
heterozygotes. Similarly, stocks for mutations on the third chromosome were 
crossed to OR22a-Gal4, UAS-mCD8::GFP; Dr/TM3 and the progeny self-crossed 
to obtain homozygous mutant flies or crossed to different mutant stocks to obtain 
trans-heterozygotes on the third chromosome and OR22a-Gal4, UAS-
mCD8::GFP on the second chromosome.  Flies were raised and maintained on 
standard Drosophila media at 25°C.  All lines were obtained from the 
Bloomington Stock Center except the following: Toll 6, Toll 7, and Toll 8 mutants 
(gifts from Yoshimasa Yagi, Nagoya University, Nagoya, Japan), ninjurin mutants 
(gifts of Andrea Page-McCaw), IkappaB kinase-like 2 and IMD mutants (gifts 
from Neal Silverman), all Calx lines (gifts from Craig Montell), all Lkb1 lines (gifts 
from Daniel St. Johnston), ca-alpha-1Dx10,FRT40a , cacHC129,FRT19A , cacHC129, 
FRT19A ; ca-alpha-1Dx10, FRT40A , FRTG13,Df(2R)RyR1 , FRT82B,IP3Rsv35 , 
FRTG13,dOraiA355 , calp-B1 , calpA72 , calpA75 , ca-beta10 , and ca-beta48 (gifts 
from Kazuo Emoto), and mouse knock-outs of Unc93B, Tlr3, and Tril (gifts from 
Kate Fitzgerald). 
For mouse lines, rearing/handling and surgeries were performed by 
technicians in the lab under established protocols and IACUC approval.  Plastic 
embedded sciatic nerves that had been transected 7 days prior to harvest were 
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obtained from the electron microscopy core at UMass Medical School.  Semi-thin 
1m sections were made using a glass knife, heat fixed, and stained with toluidine 
blue.   
The Wallerian degeneration assay was performed as previously 
described67.  Flies were aged for 7 days after eclosion to permit strong 
expression of the mCD8::GFP marker.  The left third antennal segments were 
then removed with forceps, and the flies aged for 7 days at 25°C.  Fly heads 
were then removed and fixed in 4% formaldehyde/PBS/0.1% Tween and the 
brains dissected.  Fly brains were then mounted in Vectashield antifade (Vector 
Laboratories) and imaged on a Zeiss spinning disc confocal microscope 
(Intelligent Imaging Innovations, Denver, CO). 
 
Results 
Three main phenotypes were expected from this screen: wild type (WT), 
where axons degenerate and are cleared fully by 7 days after ablation; intact, 
where the axons failed to degenerate normally, as in Wlds-expressing neurons; 
and extra debris, where axons degenerated but were not cleared.  Figure II-1 
gives an example of each of these phenotypes; in each case, intact axons 
appear on the left and injured axons on the right.  In WT, injured axons have 
degenerated and been cleared by surrounding glia; those uninjured axons that 
remain synapse on their olfactory glomeruli, cross through the midline 
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commissure and synapse on the contralateral glomerulus.  Intact axon 
phenotypes, such as when Wlds is expressed, resemble WT uninjured ORNs 
despite being cut off from the discarded cell bodies for 7 days.  In the extra 
debris phenotype, axons degenerate but are not cleared.  This is seen as a 
debris trail where axons normally reside, as on the right in the kayak mutant in 
Figure II-1.   
Table II-1 lists the genes tested and the lines used to do so, and the 
outcome of the assay.  In all, 217 lines were obtained and tested for defects in 
WD.  With several of the lines tested the mutants used were not compatible with 
life in the adult fly, and these were marked as non-viable (NV) combinations.  NV 
crosses were observed for 22 lines or combination of lines.  Normal axon 
degeneration and clearance was observed in the majority of cases: 199/265 
combinations tested.  31 genotypes tested showed debris left at day 7 after 
ablation.  This phenotype could be due to a defect in glial activation or 
engulfment of the axonal debris, or it could be a failure within the axons to 
produce a signal to activate the glia.  The strongest engulfment phenotype was 
seen with an allele of the kayak gene, which encodes the Drosophila c-fos, a 
transcription factor downstream of JNK (Figure II-1).  Notably, this phenotype 
was subsequently confirmed in an axonal engulfment assay with RNAi knock 
down of glial kayak71. 
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Figure II-1. Wallerian degeneration of Drosophila olfactory receptor 
neurons: wild-type and mutant phenotypes. 
Olfactory receptor neurons project axons (arrow) through the fly brain to synapse 
in the ipsilateral glomerulus (circled), cross the midline (red line), and synapse on 
the contralateral glomerulus.  When ablated, the axons undergo Wallerian 
degeneration, and are cleared by 7 days post ablation.  The arrowhead denotes 
the region where the axons were prior to degeneration.  When WLDs is 
expressed in these neurons, ablated axons remain intact (red arrow).  Some 
mutations, such as in kayak, prevent the clearance of degenerated axons, extra 
debris remains (red arrow head).  Neurons were labelled by the olfactory 
receptor neuron marker OR22a-Gal4 driving expression of a membrane-localized 
green fluorescent protein. 
25 
 
Table II-1. Literature candidate lines tested for defects in Wallerian degenration. 
 
Gene Stock Number Phenotype 
  NV = not viable 
   
Toll 2507 
none (3238/25052), (2507/3238)  
some debris (25052/2507) 
Toll 3238 
Toll 25052 
18Wheeler 4372 
some had quite a lot of debris 18Wheeler 543 
MstProx 2057 
none (2057 alone and with 7625) MstProx 7625 
Tehao 9594 none 
Toll-6 25412 NV 
Toll-6 
Yagi 
none 
Toll-7 none 
Toll-7 30588 none 
Tollo Yagi none 
Toll-9 29264 
none, 29264 alone-none Toll-9 26519 
Calx Montell none 
Calx Montell none 
Calx Montell none 
Calx Montell none 
Calx Montell none 
IK2 Silverman none 
IMD Silverman none 
TRXT1/2 4557 none 
dunce 6020 none 
licorne 11880 extra debris 
Clic 12267 none 
CG3719 21105 none 
CaMK1 16799 none 
SERCA 25434 
debris; weak (d5) SERCA 25443 
SERCA 26700 debris (d5)-25434  none-25443 
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kayak 15018 lots of debris - strong 
TRAF-like 26869 none 
TRAF-4 17285 
none (none 17285 alone too) TRAF-4 9694 
TRAF-6 29989 debris (weak) 
rdg-C 30627 
none + 30627 alone rdg-C 3601 
lic and hep 9058 
NV 
hep 6761 
hep 10082 
Mkk4 17956 
NV Mkk4 7628 
EGFR-CA 9534 degeneration with Pi3Kcaax 
LON 27141 
none LON 7945 
gdh 7675 
none(7992/20165 and 
7675/20165) 
gdh 7992 
gdh 20165 
diff. gdh 27841 
none diff. gdh 7990 
twinkle 26949 
none twinkle 7508 
aconitase 26445 
none aconitase 20708 
aconitase 24609 none 
aconitase 14849 none 
cacophony 8579 none 
slo 29918 none 
slo 4587 none 
SPG7 18149 none 
SPG8 18967 none 
CG6724 7820 
none: 7820/21128, 21128/18019 
CG6724 18019 
CG6724 21128 
Tehao 27383 extra debris (d5) with 9594 
Mpk2 8822 none 
p38b 22319 
none (14364 alone: none) p38b 14364 
p38c 14126 none 
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CG4709 27442 none 
starvin 11501 
none starvin 7598 
chip 16378 none 
CG11486 17263 
none (20352 alone - none) CG11486 20352 
CG8232 18295 lots of debris at d5 
calcineurin A1 29211 
none: 24142/26847, 
29211/24142, 26847/29211, 
29211 
calcineurin A1 24142 
calcineurin A1 26847 
CG3714 17075 
none CG3714 9600 
CG10496 22415 
none: 11716/22415, 11657, 
22415/11657, 11716 
CG10496 11657 
CG10496 11716 
CG9062 24352 
NV CG9062 24382 
GS1 6248 
slight debris; wiring defect GS1 27940 
Csp 32035 
debris Csp 20497 
Drep-1 12531 
none Drep-1 26551 
vermillion 856 
none, all combinations 
vermillion 142 
vermillion 3109 
det 17963 
NV det 25388 
Cyp1 10136 none alone, trans: ectopic 
connections + weak debris Cyp1 27415 
Frq1 34397 34397/8939 none 
Frq2 1739 unhappy axons, slight debris 
Frq2 18939 none 
pelle 3111 
none 
pelle 3112 
pelle 7686 
tube 3116 
none tube 9538 
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dMyd88/Kra 14091 23665/14091 and 14091 alone: 
engulf/delay dMyd88/Kra 23665 
tep3 19199 
9619/19199 weak delay; 19199 
none 
tep3 29239 
tep3 9619 
tep4 15936 none 
Pkc delta 25698 extra debris 
gd 15472 none 
snake 3114 
NV snake 7973 
CG9095 19310 
none 
CG9095 22433 
CG9095 26595 
CG6459 7890 7890/18627 none; 18627 slight 
debris CG6459 18627 
iPLA2-VIA 15947 
15947 wiring, sometimes debris; 
24417/15947 & 24417/15947 
wiring defect? Occasonal axon 
on injured side; 24418/24417 NV 
iPLA2-VIA 24418 
iPLA2-VIA 24417 
CG8232 9063 none 
CG9906 23296 none 
CG9906 26858 none 
Cnx99A 17136 
none Cnx99A 8925 
crc 9227 
9227/25056 NV; 13125 
13125/9227 25056/13125 none 
crc 25056 
crc 13125 
vha55 1617 NV 
vha55 9445 
NV vha55 9446 
Vha100-2 19975 none 
Vha100-2 21709 21709 some with debris; 
21709/7657 some with debris; 
19975/7657 none; 11656/7657 
NV 
Vha100-2 11656 
Vha100-2 7657 
ltd 338 
23664/338 and 338 alone: some 
debris 
ltd 24448 
ltd 23664 
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AIP4 17664 none 
Duox 16468 NV 
poe 11758 
11758/11761 none poe 11761 
CG42271 18046 none 
angel 27351 
NV angel 9424 
CG9391 16929 
16929 axons and glomeruli look 
sick; 24923/16929 none CG9391 
24923 
iav 6029 none 
nan 24902 
none nan 24903 
egr Silverman none 
egr Silverman none 
PI3K 8294 none 
sina 30724 no clones 
eff 11779 none 
ipk2 Freeman stocks none 
strica McCall none 
dredd McCall none 
dronc McCall none 
ninjurin A Page-McCaw none 
ninjurin B Page-McCaw none 
ninjurin A/B Page-McCaw mild/moderate debris 
DCP1 McCall some minor debris 
DCP1 McCall some minor debris 
LKB1 St.Johnston none 
LKB1 St.Johnston none 
LKB1 St.Johnston none 
ca-α1D Emoto debris d8; fragmented 24hr 
cacophony Emoto debris d8; fragmented 24hr 
cac;ca-α1D Emoto debris d8; fragmented 24hr 
RyR Emoto none 
IP3R Emoto none 
orai Emoto none 
calpain B1 Emoto none 
calpain A Emoto none 
ca-beta Emoto debris d8; fragmented 24hr 
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mouse genes   
TLR3 Kate Fitzgerald KO 
UNC93B Kate Fitzgerald KO 
TRIL Kate Fitzgerald KO 
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Figure II-2. Sciatic nerves degenerate after injury in Tlr3 and Unc93B 
mutant mice. 
Toluidine blue staining of sciatic nerves 7 days after surgical cut.  In wild-type as 
well as Tlr3 and Unc93B mutant mice, Wallerian degeneration occurs normally.  
Images are of sciatic nerve distal to the cut.  
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Candidates Identified by Mouse Proteomics 
The following is adapted from: Wishart, et al, PLoS Genet. 012;8(8):e1002936, of 
which I was second author, and I performed all the Drosophila work below99. 
 
Materials and Methods 
Drosophila degeneration screen 
Drosophila orthologs of the designated mouse proteins were identified, 
when available, using a reciprocal BLASTing approach and the Ensembl website 
(ensemble.org). Available mutations were identified in Flybase; the 
following Drosophila mutant stocks were obtained from the Bloomington Stock 
Center (Bloomington ID #): 12900, 26277, 18382, 7762, 20497, 12301, 30075, 
24665, 18046, 5595, 23173, 6671, 13491, 20672, 25213, 18502, 13446, 9109, 
11876, 7084, 25107, 7938, 5708, 11734, 29228, 2247, 13491, 15889, 8479, 
18884, 23097, 15642, 382, 32035, and 7617. Mutant stocks on the X 
chromosome were crossed to OR22a-Gal4, UAS-mCD8::GFP flies and males 
were used for the degeneration screen. Stocks for mutants on the second 
chromosome were crossed to Sp/Cyo; OR22a-Gal4, UAS-mCD8::GFP, and the 
progeny were self-crossed to obtain homozygous mutant flies on the second 
and OR22a-Gal4, UAS-mCD8::GFP on the third chromosome. Similarly, stocks 
for mutants on the third chromosome were crossed to OR22a-Gal4, UAS-
mCD8::GFP; Dr/TM3 and the progeny self-crossed to obtain homozygous mutant 
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flies on the third chromosome and OR22a-Gal4, UAS-mCD8::GFP on the second 
chromosome. 
The Wallerian degeneration assay was performed as described67ma. 
Briefly, flies were aged for 7 days after eclosion to allow strong labeling of ORN 
axons with GFP. The left 3rd antennal segment was then removed, and the flies 
aged for another 7 days. The right antennal ORNs served as unlesioned controls. 
The fly heads were then fixed in 4% formaldehyde/PBS/0.1% Tween, and the 
brains dissected. Fly brains were mounted in Vectashield and examined by 
confocal microscopy where they were phenotypically scored by an investigator 
who was unaware of the genotype. A minimum of 10 animals were examined and 
assessed per mutant strain. 
Spontaneous degeneration in uninjured axons and synapses was scored 
by eye using the following criteria: 0 = no evidence for fragmentation of axons or 
loss of GFP fluorescence in the glomerulus; 1 = <10% of axons showing 
fragmentation and/or mild loss of GFP fluorescence in the glomerulus; 2 = <25% 
of axons showing fragmentation and/or mild to moderate loss of GFP 
fluorescence in the glomerulus; 3 = >50% of axons showing fragmentation and/or 
moderate to severe loss of GFP fluorescence in the glomerulus; 4 = only 
fragmented axons remaining and/or severe loss of GFP fluorescence in the 
glomerulus; 5 = no GFP signal remaining in axons or the glomerulus. Delayed 
degeneration in injured axons and synapses was scored by eye using the 
following criteria: 0 = no intact axons and no fragments remaining; 1 = no intact 
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axons but fragmented debris remaining; 2 = ~25% of axons intact but with 
extensive fragmentation of surrounding axons; 3 = ~50% of axons intact with 
evidence for fragmentation in surrounding axons; 4 = >75% of axons intact with 
only modest amounts of fragmentation in surrounding axons; 5 = intact axons 
and synapses with no evidence for fragmentation. 
 
Results 
Identification of individual proteins capable of independently regulating 
synapse and distal axon degeneration in vivo 
Although we had obtained a clear understanding of conserved molecular 
alterations occurring in synapse-enriched fractions undergoing 
neurodegeneration, it remained unclear whether or not any of the proteins and 
pathways identified were capable of actively modulating synaptic and axonal 
stability and degeneration in vivo. We therefore used a molecular genetic 
approach in Drosophila to screen individual proteins for a direct role in 
neurodegeneration. 
We examined the role of individual proteins in regulating synaptic stability 
and degeneration using the Drosophila olfactory system to screen a collection of 
existing mutants, or lines with transposon insertions in a subset of these genes. 
Briefly, mutants and insertion lines were crossed in to a background that allowed 
visualization of a subset of olfactory receptor neurons (ORNs; OR22a-Gal4/UAS-
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mCD8::GFP). Distal axons and their synaptic fields in the antennal lobe were 
examined in uninjured controls as well as 7 days after surgical ablation of 
antennae. Examining uninjured controls allowed us to screen individual mutant 
lines and test whether they modified basal synaptic and axonal stability (e.g. do 
synapses and axons degenerate spontaneously in the mutant line?). 
Spontaneous degeneration was identified by the presence of fragmented 
axons and absence/decrease of GFP signal in the glomeruli housing synaptic 
terminals of ORNs and scored using a spontaneous degeneration index, where a 
score of 0 represented no disruption of axons or synapses in the glomerulus and 
5 indicated complete spontaneous breakdown (see methods). Surgical ablation 
of antennae triggered rapid axonal and synaptic degeneration, which is complete 
within one day in wild-type controls, and axonal debris is cleared within one week 
after injury. Screening individual mutant lines 7 days after surgical ablation 
therefore allowed us to examine whether any of the mutations resulted in a delay 
in the rate of injury-induced degeneration, scored using a delayed degeneration 
index where a score of 0 indicated no delay in degeneration and 5 indicated a 
complete block. 
From our original list of 47 synaptic proteins we obtained Drosophila lines 
for 21 different genes that harbored either defined mutations known to affect that 
gene, or P element insertions within the locus identified by the Drosophila 
Genome Project (see methods). Of the 34 mutant lines obtained, 14 produced 
viable flies suitable for analyses of axonal and synaptic stability and degeneration 
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(covering a total of 13 individual proteins; Table II-2). Eight of the lines examined 
showed no overt phenotype in either stability or degeneration assays (Table II-2). 
However, 6 mutant lines were found to independently modulate stability or 
degeneration of distal axons and synapses in ORNs. Mutants of both ALDHA1 
and DNAJC6/Auxillin caused spontaneous degeneration of distal axons and 
synaptic terminals in uninjured ORNs (Figure II-3). In contrast, mutations 
affecting CALB2/Calretinin, DNAJC5/CSP, HIBCH and ROCK2 caused a partial 
delay of injury-induced WD of axons and synapses (Figure II-3). In each of these 
lines, intact distal axons or axonal fragments were observed 7 days after 
experimental nerve lesion, a time-point at which axonal remnants were never 
observed in wild-type flies (data not shown). 
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TABLE II-2: List of viable Drosophila lines tested in the current study.   
(Adapted from Wishart, et al, PLoS Genet. 2012;8(8):e1002936) 
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Wishart, et al, PLoS Genet. 2012;8(8):e1002936 
FIGURE II-3. Overview of putative axo-synaptic degeneration phenotypes 
observed in Drosophila neurodegeneration screens. 
A. Representative confocal micrograph showing the morphology of the intact 
Drosophila olfactory receptor neuron (ORN) system, with axons and synaptic 
fields labeled with GFP in the UAS-mCD8::GFP,OR22a-Gal4/+ background. 
Axons enter the antennal lobe laterally and project medially across the lobe to 
reach their target glomerulus, where synapses are located (see Figure II-1). B. 
Representative confocal micrographs showing three distinct phenotypic profiles 
observed in injured and un-injured ORN axons and synapses 7 days after 
unilateral (right hand side of image) antennal ablation. The top panel shows 
intact healthy axons and synapses on the uninjured side and complete axonal 
degeneration (indicated by absence of GFP labeled profiles) on the injured side 
(example from an NFASC mutant). The middle panel shows delayed axo-
synaptic degeneration on the injured side, as indicated by the retention of GFP-
labelled axon profiles 7 days after injury (white arrow; example from a ROCK2 
mutant). The bottom panel shows spontaneous (i.e. not injury-induced) axo-
synaptic degeneration in the uninjured axons and synapses, indicated by 
reduction and fragmentation of GFP labeled axons and synapses (white arrows; 
example from a DNAJC6 mutant). C. Bar chart (mean±SEM) showing index 
scores (see methods) for spontaneous degeneration (S; grey bars) and delayed 
degeneration (D; black bars) in 7 mutant Drosophila lines. OGDH is shown as an 
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example of a mutant line with no overt phenotype. DNAJC6 and ALDH1A1 
mutants revealed evidence for spontaneous degeneration in the absence of any 
injury stimulus. DNAJC5, CALB2, ROCK2 and HIBCH mutants revealed 
evidence for delayed degeneration following antennal ablation.   
(Adapted from Wishart, et al, 2012) 
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To provide more robust genetic evidence for a role for one of these 
proteins (DNAJC5/CSP) in axonal and synaptic degeneration, we obtained two 
additional alleles: cspX1, a loss of function allele which deletes the first exon of 
csp; and Df(3R)Exel6138, a deletion which completely removes the csp locus. 
Both cspX1 and Df(3R)Exel6138 failed to complement the delay in axonal 
degeneration observed with our original allele (cspDG29203), thereby mapping this 
phenotype to the csp locus (Figure II-4). We further note that the severity of the 
delay in axonal degeneration appeared to be enhanced when cspDG29203 was 
placed over either of these null alleles of csp, which argues that cspDG29203 is a 
weak loss of function allele. 
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FIGURE II-4. Detailed genetic analysis confirms DNAJC5/CSP as a robust 
regulator of axo-synaptic degeneration in vivo. 
Representative confocal micrographs showing axon degeneration profiles in wild-
type (WT) flies and additional DNAJC5/CSP lines: cspX1, a loss of function allele 
which deletes the first exon of csp; and Df(3R)Exel6138, a deletion which 
completely removes the csp locus. Examples are shown of uninjured axons (left 
panels), unilaterally injured axons (middle panels) and bilaterally injured axons 
(right panels). Both cspX1 and Df(3R)Exel6138 failed to complement the delay in 
axonal degeneration observed with our original allele (cspDG29203), thereby 
mapping this phenotype to the csp locus. Note how the severity of the delay in 
axonal degeneration was enhanced when cspDG29203 was placed over either of 
these null alleles of csp, suggesting that cspDG29203 is a weak loss of function 
allele.  Neurons were labelled by the olfactory receptor neuron marker OR22a-
Gal4 driving expression of a membrane-localized green fluorescent protein. 
(Adapted from Wishart, et al, 2012) 
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Thus, several individual proteins initially identified as a result of having 
modified expression levels in synapse-enriched fractions undergoing 
neurodegeneration appear capable of directly influencing synaptic and axonal 
stability and degeneration in Drosophila. In addition, our work rigorously defines 
the role of DNAJC5/CSP as an in vivo regulator of synaptic and axonal 
degeneration. 
 
 
Unbiased Screening of the Drosophila 2nd Chromosome 
The MARCM system allows for the analysis of cells homozygous for a 
particular chromosomal arm in an otherwise heterozygous animal98.  This is done 
using flippase-based mitotic recombination of entire chromosomal arms that have 
Flippase Recognition Target (FRT) sites inserted near the centrosome.  During 
mitosis, heterozygous cells give rise to daughter cells homozygous for one 
parental chromosomal arm via flippase-mediated recombination – one cell 
inherits two copies of the same parental arm and the other cell inherits the two 
copies of the other parental arm. In the MARCM animal, one parental arm 
typically carries a lethal mutation while the homologous arm contains a tubulin-
driven Gal80 that acts as an inhibitor of Gal4 drivers.  In the heterozygous 
animal, Gal4 is silenced by Gal80 in all cells.  Upon mitotic recombination by 
flippase, cells that inherit two copies of Gal80 remain unmarked.  The cells that 
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inherit two copies of the other (typically mutant) arm do not inherit Gal80, and are 
thus marked by the Gal4 driver being used.  Thus, the MARCM clones observed 
occur in the intersection between the pattern of expression of the flippase and 
that of the Gal4 driver. 
Ethyl methanesulfonate (EMS) is used as a mutagen in flies to create 
randomly mutagenized stocks that can be screened for various phenotypes100.  
EMS induces mutations by reacting with guanine nucleotides in DNA.  The 
subsequent adducts are either repaired incorrectly or cause incorrect base 
pairing during DNA replication, causing random DNA mutations. 
Chromosomal deletions, also called deficiencies (Df), are useful tools in 
the mapping and characterization of novel mutations100.  The Exelixis company 
has created whole collections of deletions with well-mapped endpoints that tile 
over 50% of the entire fly genome, providing precise information about which 
genes are uncovered by these deletions101.  I used part of this collection to test 
whether any of the deletions would show a defect in Wallerian degeneration.  If 
so, then I could test all of the small number of genes known to be uncovered by 
that deletion with other available reagents, or create new reagents targeting 
those genes.   
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MARCM Analysis of WD Using Chromosome 2L Deficiency Lines 
Materials and Methods 
MARCM-ready Drosophila stocks with deletions on chromosome 2L were 
previously established in the laboratory of Marc Freeman, PhD by recombining 
the deletions onto a WT FRT chromosome.  An isogenized stock of FRT40A on 
the left arm of chromosome 2 was recombined with the individual stocks from the 
Exelixis collection of deletions on chromosomal arm 2L that is available from the 
Bloomington Stock Center.  The generic genotype for these lines is 
Df(2L)Exel####,FRT40A.  These lines were crossed to the following MARCM 
tester stock: ey-FLP, UAS-mCD8::GFP ; tub-Gal80, FRT40A ; OR22a-Gal4, 
UAS-mCD8::GFP.  ey-FLP induces flippase activity in the developing eye and 
antennal discs, resulting in MARCM clones in the adult structures.  A subset of 
ORNs were labelled with the OR22a promotor driving expression of a 
membrane-bound GFP.  The Wallerian degeneration assay was performed as 
previously described67.  Briefly, flies were aged for 7 days after eclosion to permit 
strong expression of the mCD8::GFP marker.  The left third antennal segments 
were then removed with forceps, and the flies aged for 7 days at 25C.  Fly heads 
were then removed and fixed in 4% formaldehyde/PBS/0.1% Tween and the 
brains dissected.  Fly brains were then mounted in Vectashield antifade (Vector 
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Laboratories) and imaged on a Zeiss spinning disc confocal microscope 
(Intelligent Imaging Innovations, Denver, CO). 
 
Results 
When crossed to the tester stock: ey-FLP, UAS-mCD8::GFP ; tub-Gal80, 
FRT40A ; OR22a-Gal4, UAS-mCD8::GFP, clones homozygous for the deficiency 
were generated in the developing eyes and antennae, a subset of which were 
marked with the olfactory receptor neuron driver OR22a-Gal4.  These animals 
were tested in the ORN Wallerian degeneration assay, as described above.  Four 
main phenotypes were expected from this screen: 1 – no phenotype, where 
axons degenerate and are cleared normally; 2 - debris, where axons 
degenerated but were not cleared.  Due to the cell autonomy afforded to the 
neurons via MARCM, this could be due to a defect in “eat-me” cues where 
degenerating axons fail to signal to surrounding glia; 3 - intact, where the axons 
failed to degenerate normally; and 4 – no clones/cell lethal when no clones were 
observed in the adult brain.  This could be due to either a failure in MARCM 
clone production, or to cell lethality of the homozygous deletion.  Table II-3 lists 
the lines tested and results.  Most of the lines did not produce testable clones in 
the ORN system – 35 out of 57 tested, even when repeated.  In the other 22 
lines, no phenotype was observed, meaning axon degeneration and glial 
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clearance of the debris proceeded normally.  In these 22 lines, the genes 
uncovered likely do not participate in WD. 
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No Phenotype No Clones/Cell Lethal 
Df(2L)Exel6011  Df(2L)Exel7042  Df(2L)Exel6001  Df(2L)Exel6277  
Df(2L)Exel6014  Df(2L)Exel7046  Df(2L)Exel6002  Df(2L)Exel7002  
Df(2L)Exel6016  Df(2L)Exel7048  Df(2L)Exel6003  Df(2L)Exel7006  
Df(2L)Exel6029  Df(2L)Exel8008  Df(2L)Exel6004  Df(2L)Exel7007  
Df(2L)Exel6030  Df(2L)Exel8010  Df(2L)Exel6005  Df(2L)Exel7008  
Df(2L)Exel6038  Df(2L)Exel8016  Df(2L)Exel6006  Df(2L)Exel7014  
Df(2L)Exel6256  Df(2L)Exel8019  Df(2L)Exel6007  Df(2L)Exel7015  
Df(2L)Exel7010  Df(2L)Exel9031  Df(2L)Exel6008  Df(2L)Exel7016  
Df(2L)Exel7022  Df(2L)Exel9032  Df(2L)Exel6009  Df(2L)Exel7021  
Df(2L)Exel7029  Df(2L)Exel9038  Df(2L)Exel6012  Df(2L)Exel7023  
Df(2L)Exel7040  Df(2L)Exel9064  Df(2L)Exel6015  Df(2L)Exel7027  
  Df(2L)Exel6021  Df(2L)Exel7038  
  Df(2L)Exel6022  Df(2L)Exel7039  
  Df(2L)Exel6027  Df(2L)Exel7043  
  Df(2L)Exel6028  Df(2L)Exel7059  
  Df(2L)Exel6034  Df(2L)Exel8012  
  Df(2L)Exel6036  Df(2L)Exel8021 
   Df(2L)Exel8034  
 
Table II-3. Deficiency lines tested for defects in Wallerian degeneration. 
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A Forward-Genetic Screen for Wallerian Degeneration Mutants 
 
Materials and Methods 
Drosophila Stocks and Injury Protocol 
The following Drosophila strains from the Bloomington stock center were 
used in this study: OR22a-Gal4,pUAST-mCD8::GFP; ey-flp; tub-Gal80,FRT2A; 
FRT82B,tub-Gal80; FRT2A,FRT82B; tub-Gal80,FRT40A; FRTG13,tub-Gal80; 
FRT40A,FRTG13. The Wallerian degeneration assay was performed as 
described above. 
 
Generation of 2nd Chromosome EMS-induced Mutant Stocks 
To make the lines needed to test for WD mutants on the 2nd chromosome 
of Drosophila, I first isogenized the double-FRT chromosome (FRT40A,FRTG13) 
so that all subsequent lines arose from one single wild type chromosome to limit 
the effects of random drift in the original stock.  The double-FRT chromosome 
contains FRT sites on both arms of chromosome 2, allowing for the independent 
MARCM analysis of both arms of a single chromosome (of a single mutant 
stock).  The isogenization step is important because the deep sequencing results 
of any mutants found are compared to those of this original stock as a reference 
genome to identify polymorphisms (hopefully in the causative gene).  A single 
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male of the stock FRT40A,FRTG13/CyO ; OR22aGal4,UAS-mCD8::GFP/TM3 
was crossed to virgins of the stock Sp/CyO ; OR22aGal4,UAS-mCD8::GFP/TM3.  
4 Individual male progeny were selected and crossed as follows:  
FRT40A,FRTG13/CyO ; OR22aGal4,UAS-mCD8::GFP/TM3   
X   
Sp/CyO ; OR22aGal4,UAS-mCD8::GFP/TM3.   
 
The progeny of these individual crosses were self-crossed to make several 
stocks of: FRT40A,FRTG13iso/CyO ; OR22aGal4,UAS-mCD8::GFP/TM3.   
To make MARCM-competent tester stocks for screening, the following lines were 
created:  
eyFLP, CD8::GFP ; tub-Gal80, FRT40A/Cyo  
eyFLP, CD8::GFP ; FRTG13, tub-Gal80/Cyo 
eyFLP induces flippase activity in developing eye and antennal structures102, 
mCD8::GFP is a Gal4-driven membrane-bound GFP, and tub-Gal80 is a 
ubiquitously expressed Gal80 that suppresses the Gal4 activation of UAS.  
These lines were then used to test the different isogenized lines to ensure that 
normal WD occurred and to test for efficient clone induction.  10 adults from the 
following crosses were assayed in the standard WD assay as described above: 
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For 2L: 
FRT40A,FRTG13iso/CyO ; OR22aGal4,UAS-mCD8::GFP/TM3 
X 
eyFLP, CD8::GFP ; tub-Gal80, FRT40A/Cyo  
 
And for 2R: 
FRT40A,FRTG13iso/CyO ; OR22aGal4,UAS-mCD8::GFP/TM3 
X 
eyFLP, CD8::GFP ; FRTG13, tub-Gal80/Cyo 
 
The percentage of adults with ORN clone induction for each line tested was 
determined for each chromosome arm: 
Line 1: FRT40A (2L): 88% 
FRTG13 (2R): 33% 
Line 2: FRT40A (2L): 60% 
FRTG13 (2R): 43% 
Line 3: FRT40A (2L): 100% 
FRTG13 (2R): 100% 
Line 4: FRT40A (2L): 100% 
FRTG13 (2R): 50% 
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As line 3 gave had the best clone induction for both arms of chromosome 
2, that line was used further and the others were discarded.  Figure II-5 shows 
the representative results of the WD assay, as well as clone induction in the 
intact side.  There are approximately 24 OR22a-Gal4-labelled ORNs per 
antennae, and due to axon bundling, typically 11-12 are discernable in the brain 
preparations shown102.  Line 3 had the best clone induction overall, and in all 
lines WD proceeded normally as there is no debris left on the ablated side 7 days 
after injury. 
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Figure II-5. MARCM clone induction and Wallerian degeneration in olfactory 
receptor neurons.  
MARCM clones were labelled by the olfactory receptor neuron marker OR22a-
Gal4 driving expression of a membrane-localized green fluorescent protein.  
Representative images from each line show the variation in clone induction (see 
intact sides on the left).  All lines showed normal Wallerian degeneration 7 days 
after ablation (right side of the images). 
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To make EMS-induced mutant stocks, I first made the following stock:   
Sp,hs-hid/CyO ; OR22aGal4,UAS-mCD8::GFP/TM3 
This line eliminates the need to collect virgins from each individual mutant cross 
to make stocks.  Rather, the crosses are heat-shocked which induces the 
expression of the pro-apoptotic gene hid.  Any progeny in the crosses that 
inherits the Sp,hs-hid chromosome will therefore die and the remaining progeny 
will be appropriately balanced.   
I then performed the following protocol twice.  First, dozens of males from 
the genotype FRT40A,FRTG13iso/CyO ; OR22aGal4,UAS-mCD8::GFP/TM3 were 
starved by placing them in empty bottles with a damp Kimwipe in the morning.  In 
the evening, I added 12.5µL EMS to 5mL 1% sucrose and mixed very well (EMS 
is oily) for each bottle of males (50-100 males per bottle).  This dilution was 
determined by the characterization of induced mutagenesis prior to the 
construction of mutant stocks for the 3rd chromosome screen.  The EMS/sucrose 
solution was then added to a Kimwipe at the bottom of an empty bottle and the 
flies were incubated in the bottle overnight.  The next morning, the flies were 
transferred to fresh bottles of food and allowed to clean themselves for 3-4 hours.  
The males were subsequently crossed with hundreds of virgins of  
Sp/CyO ; OR22aGal4,UAS-mCD8::GFP/TM3.  After 3 days, males were 
removed and females were flipped into new bottles.  The females were flipped 
into new bottles after 3 days twice more.   
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From these crosses 1994 males were collected and individually crossed 
with 4-5 virgins of the genotype: Sp,hs-hid/CyO ; OR22aGal4,UAS-
mCD8::GFP/TM3.  3 days later, the flies were discarded and the vials heat-
shocked in a 37°C water bath for 1hr, and again the next day for 1hr.  Only 3 
stocks made in this fashion had the Sp marker, indicating excellent negative 
selection of Sp,hs-hid.  The surviving 1100 stocks with EMS-induced mutations 
had the following genotype: 
*,FRT40A,FRTG13iso,* / CyO ; OR22aGal4,UAS-mCD8::GFP / TM3 
I, Nicki Fox, PhD, and later Rachel Hackett then tested these stocks in the 
standard WD assay as described above.  Stocks with homozygous viable 2nd 
chromosomes, as determined by loss of the CyO balancer, were tested as 7 day 
old adults. The 3rd chromosomal ORN driver and GFP reporter allowed us to test 
both chromosomal arms simultaneously in the 199 (18%) 2nd chromosome 
homozygous viable stocks recovered.  The remaining 901 (82%) stocks had 
homozygous lethal 2nd chromosomes, or synthetic lethal interactions that 
required MARCM analysis to determine if they were competent in WD.  Each 
stock was crossed to a tester stock for each chromosomal arm. 
For 2L: 
*,FRT40A,FRTG13iso,* / CyO ; OR22aGal4,UAS-mCD8::GFP / TM3 
X 
eyFLP, CD8::GFP ; tub-Gal80, FRT40A/Cyo  
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And for 2R: 
*,FRT40A,FRTG13iso,* / CyO ; OR22aGal4,UAS-mCD8::GFP / TM3 
X 
eyFLP, CD8::GFP ; FRTG13, tub-Gal80/Cyo 
 
Progeny of these crosses were collected and the genotypes below were assayed 
in our WD protocol (as above).   
For 2L: 
 
 
And for 2R: 
  
We felt it was important to screen enough animals per cross to make a 
solid call whether or not WD was affected in that particular line, especially 
considering that clone induction was quite variable fly-to-fly with the EMS lines.  
We therefore dissected and screened at least 7-10 brains per cross.  In lines that 
required repeating due to a lack of observed clones, anti-GFP antibody staining 
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was performed to boost any weak signal; these added steps revealed weakly 
labelled clones in some crosses. 
 
Results 
Altogether, we were able to screen through 1593 chromosomal arms.  In 
400 of these arms, no clones were visible, even after a repeat cross with anti-
GFP staining.  330 arms were tested by another graduate student, Tom Burdett, 
who tested them in the wing assay developed later103, for a grand total of 1923 
2nd chromosomal arms tested.  Much to our great dismay, none of these arms 
harbored a mutation that affected axon degeneration.   
While most of the tested chromosomal arms had no phenotype, around 20 
were classified as having a confirmed clearance defect upon repeating. For the 
viable arms tested, this could be due to loss of a neuronal eat-me cue, resulting 
in axon degeneration with a failure in the clearance by glia or it could be due to a 
defect in the glial response to axon injury.  The lethal arms tested, by virtue of the 
MARCM system, are homozygous only in the labelled neurons and any cells that 
may have expressed ey-flp when dividing in the developing eye and antennal 
discs.  As glia proliferate in the larval brain and migrate into newly developed 
brain regions like olfactory lobes during metamorphosis, and do not express ey-
flp, the cell-autonomy of the clearance defect of any lethal arms lies with the 
neurons104.  One example of a mutant of this class is TR156L.  By 24hrs after 
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ablation, the homozygous mutant TR156L axons are fragmented (data not 
shown).  However, at 7 days after ablation, debris remains; Figure II-6 shows the 
results of ablating both antennae compared to the same ablation in WT.  Arrows 
point to the synaptic zones and arrowheads point to debris.  While not all brains 
had large amounts of debris at day 7, all had more than is seen in WT 
(essentially none).  
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Figure II-6. Line TR156L exhibits a failure in debris clearance after axotomy. 
Representative MARCM clones showing wild-type (WT) and mutant (TR156L) 
phenotypes.  In WT, axonal debris is cleared by 7 days after axotomy, with minor 
synaptic debris visible on the glomeruli (arrows).  TR156L shows extra synaptic 
(arrows) and axonal (arrow heads) debris 7 days after axotomy.  MARCM clones 
were labelled by the olfactory receptor neuron marker OR22a-Gal4 driving 
expression of a membrane-localized green fluorescent protein. 
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Discussion 
 
I have not failed 10,000 times. I have not failed once. I have succeeded in 
proving that those 10,000 ways will not work. When I have eliminated the 
ways that will not work, I will find the way that will work. 
 -Thomas Edison, attributed 
 
Candidates from the Literature 
The objective of this work was to identify genes that when mutated gave 
an axon degeneration phenotype.  The genes tested were gleaned from the 
literature as candidates based on their involvement in other cell death or 
signaling pathways, on being implicated to interact with SARM proteins, or on 
their involvement in other pathways that could play a role in axon degeneration 
based on assumptions about the process of degeneration and how Wlds might 
prevent it.  As none of the 213 lines tested resulted in intact axons after axotomy, 
most were not investigated further.  Genotypes that resulted in extra debris 
remaining fall into 2 broad categories: immune/kinase signaling, and calcium 
regulation. 
Genes in the immune signaling category include: Toll, 18wheeler (Toll2), 
Tehao (Toll5), and Traf6.  Toll receptors are a large family of receptors that 
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regulate many aspects of immunity80.  The mammalian ortholog of Traf6 is an 
adapter of the TNF receptor, and has been linked with JNK signaling in necrotic 
cell death105, and also PKCδ /JNK/c-Jun in cell adhesion106.  Interestingly, both 
Pkcδ and kayak mutants had extra debris in the screen.  Kayak is the Drosophila 
ortholog of Fos that partners with Jun to form the AP-1 transcription factor that 
regulates the transcription of many genes in various cell processes67.  Alterations 
in these pathways could indeed delay axon degeneration or interfere with the 
production of an eat-me cue.  However, since whole-animal mutants were tested, 
the cell-autonomy of the defect cannot be determined.  It is more likely, given the 
immune function of most of the genes in the category, that glial clearance of 
debris is compromised.  In support of this hypothesis, the kayak allele tested, 
which had the strongest phenotype in the screen, was later shown to be required 
in glia for the appropriate clearance of degenerated axons71.  Therefore, it is 
likely that these other genes also work in glia to regulate the clearance of 
degenerated axons. 
The other category centers on the regulation of calcium ions in the cell.  
These were tested because the influx of extracellular calcium is necessary and 
sufficient for axon degeneration.  The genes include: SERCA, ca-α1D, 
cacophony, and ca-β.  SERCA is a calcium ATPase that regulates endoplasmic 
reticulum calcium levels, and is required for calcium signaling in Drosophila 
neurons107.  Though influx of extracellular, and not intracellular store-based 
release are required for axon degeneration, edoplasmic reticulum is intimately 
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linked with calcium dysregulation in cell death pathways and is also found in 
axons107. 
ca-α1D, cacophony, and ca-β all encode voltage-gated calcium channel 
subunits, and were tested as they could be part of the channels that allow 
calcium influx after axotomy.  Ca-α1D is the Drosophila ortholog of mammalian 
α1 subunit of the Cav1 L-type channels, Cacophony is the orthologous α1 
subunit of the Cav2 P/Q, N, and R-type channels, and Ca-β is the β subunit of 
Cavβ channels108.  The ca-β mutants are viable, and both resulted in debris at 
day 8 indicating a defect in clearance.  However, axons were degenerated by 
24hrs after injury, indicating that there was not a delay in axon degeneration.  
That debris remains at day 8 could mean that the glia are not activated 
appropriately or that they are incompetent in clearing the axonal debris.   ca-α1D 
and cacophony mutants are both lethal, and so were tested with MARCM 
individually as well as in a double MARCM system to generate neurons that are 
homozygous mutant for both genes.  In all cases, similar to the ca-β mutants, 
axons were fragmented by 24hrs with debris remaining by 8 days after axotomy.  
It is thus possible that voltage-gated calcium channels participate in the 
production of injury-induced eat-me cues that signal to surrounding glia to clear 
degenerated axonal debris.  The notion that L-type calcium channels are 
required for axon degeneration has only been tested pharmacologically; 
therefore these assays were an attempt to test them genetically.  The results 
suggest that these channels do not participate in the calcium influx required for 
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axon degeneration.  In epithelial injury in C. elegans, TRPM gates the calcium 
influx109.  It is thus possible that TRPM also operates in axon degeneration to 
increase intra-axonal calcium levels leading to degeneration.  We are currently 
testing mutants of Trpm in the axotomy assay. 
 
Candidates Identified by Mouse Proteomics 
The objective of this work was to test genes identified by our collaborators 
in the axotomy assay to see if they could delay WD, which encompasses axon 
degeneration as well as the clearance of axonal debris.  Our collaborators 
identified mouse proteins that were differentially regulated during WD when 
comparing WT and Wlds mouse synaptosomal preparations99.  I identified and 
tested mutant lines in the orthologous Drosophila genes in the ORN axotomy 
assay.  While none of the genotypes had intact axons at 7 days after axotomy, 4 
showed axonal debris and 2 showed spontaneous degeneration of intact axons 
at this time point.  All but HIBCH, which causes a progressive neuropathy when 
mutated, have been implicated in synaptic function110.  DNAJC5/CSP has been 
shown to participate in the assembly of SNARE complexes111, DNAJC6 likely 
participates in vesicle recycling112,113, and ROCK2, CALB2/Calretinin, and 
ALDHA1 participate in synaptic plasticity114–116.  The identification of genes 
involved in synaptic plasticity and function is consistent with the fact that these 
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genes were identified via proteomic analysis of mouse synaptosomal 
preparations.  The way these mutants influence WD is unclear.   
We chose to further examine csp mutants as the level of debris was 
considerable at day 7.  An additional loss of function allele and a deletion line 
gave stronger phenotypes, and together with phenotypic complementation 
assays directly indicate DNAJC5/CSP as a regulator of WD.  The caveat of cell 
autonomy still applies, as these where whole-animal mutants that were tested.  
However, the results imply a conservation in genes required during WD for the 
appropriate degeneration and clearance of axonal and synaptic debris. 
 
MARCM Screening of EMS-generated Mutants on the Drosophila 2nd 
Chromosome 
The objective of this work was to screen for mutations that prevent the 
appropriate degeneration of axons after axotomy.  This screening strategy has so 
far identified one novel bona fide regulator of axon degeneration: dsarm.  Many 
mutations were also found in the hiw gene, however hiw and the mouse homolog 
Phr1 were already known to regulate axon degeneration.   
Some mutant chromosomal arms tested exhibited the interesting 
phenotype of neuronal cell-autonomous defects in glial clearance of axonal 
debris, the strongest being TR156L.  As MARCM was used to analyze the line, 
the phenotype appears to be cell-autonomous to the neurons.  Dominant effects 
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of a mutation on the right arm (or other chromosomes) of the mutant stock could 
possibly affect glial clearance of debris remaining.  Examining WD in the mutant 
stock as-is or crossed to WT would rule out this possibility.  This mutant and the 
reference stock were deep sequenced and the SNPs identified on each left 2nd 
chromosome arm compared.  Unfortunately, no divergent coding changes were 
identified.  Given the lack of other stocks/complementation groups with which to 
compare, the investigation into this line was not further pursued. 
Screening through the mutant lines was hindered by the number of arms 
that did not give MARCM clones, precluding any phenotypic analysis.  
Approximately 240 arms (11%) were not able to be screened for this reason.  
These arms are presumed to have cell- or ORN-lethal mutations that prevent 
homozygous mutant clones.  They could also have EMS-destroyed FRT sites, 
which would prevent the flip event that creates a MARCM clone.   
The vast majority of the stocks harbored homozygous lethal mutations 
(approximately 849 / 1049 total, 80%), indicating that the EMS-induced 
mutagenesis was adequate.  We used a titer of EMS that would produce many 
mutations per chromosome in order to test multiple genes per chromosomal arm.  
However, this “multitasking” should be balanced with the ability to produce 
assayable clones.  There are approximately 24 OR22a-labelled ORNs per 
antenna, however there are ~600 ORNs total in each 3rd antennal segment.  It 
seems possible that increasing the number of labelled cells in the system could 
result in a greater chance of creating induced clones.  Using a pan-ORN driver 
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such as OR83b-Gal4 could therefore increase the number of testable lines 
showing MARCM clones. 
Though this screening effort failed to produce novel regulators of axon 
degeneration, I still believe that in the study of Wallerian degeneration the most 
important work remains in delineating the pathway that controls this process. 
 Thomas Edison’s words seem well suited to inspire persistence, though 
possibly they pertain better to iterative rather than repetitive processes.  Writing 
this chapter, I cannot help but be reminded of my screening anthem that seemed 
to be played more than randomly as I sat day after day in the fly room in my 
(screening) chair: 
Sitting on an angry chair 
Angry walls that steal the air 
Stomach hurts and I don't care 
 
What do I see across the way, hey 
See myself molded in clay, oh 
Stares at me, yeah I'm afraid, hey 
Changing the shape of his face, aw yeah… 
 
…Loneliness is not a phase 
Field of pain is where I graze 
Serenity is far away 
 
Excerpted from: Alice in Chains. “Angry Chair.”  Dirt. 
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Chapter III: Genes Required for Wallerian Degeneration 
also Govern Dendrite Degeneration after Injury 
 
Introduction 
Neuronal connectivity, and therefore function, relies on the proper 
maintenance and operation of neurite processes.  Dendrites and axons can 
exhibit extremely lengthy, varied, and elaborate forms.  As such, they are 
vulnerable to various insults resulting from trauma, hypoxia/ischemia, and 
neurodegenerative diseases.  When injured, dendrites and axons follow a 
stereotyped process of degeneration and clearance by neighboring cells, called 
Wallerian degeneration (WD)57.  This process in axons is regulated by calcium, 
as the influx of extracellular calcium is both necessary and sufficient for WD46.   
WD was long thought to be the result of the neurite being cut off from its 
lifeline the cell body.  25 years ago the fortuitous discovery of the Wlds mouse 
(for slow Wallerian degeneration) questioned the assumption that WD was a 
passive process of deterioration27.  Eventually we came to understand that the 
Wlds mutation created a new gene, that when expressed in neurons could 
preserve the structure and function of a severed axon for weeks instead of 1-2 
days28.  This preservation of neurites by WLDs is now known to extend from fly 
axons and dendrites to mouse axons and even human cells117.  It is not known 
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exactly how WLDs protects neurites, but recent studies have linked increased 
mitochondrial motility, ATP production, and axonal calcium buffering to axon 
preservation118.   
The protection afforded dendrites and axons by WLDs is remarkable.  
However, the exogenous gain of function nature of WLDs makes it inherently 
difficult to study the process of WD.  Therefore, identifying endogenous 
regulators of WD is important to parse out this process as well as provide 
therapeutic targets for neurite insults resulting from trauma or disease.  Recently, 
we and others identified dsarm/Sarm1 as an endogenous, robust regulator of 
axon degeneration68,87.  Mutations in this gene allow severed axons to remain 
intact several weeks in flies and mice, a level similar to that seen with WLDs.  
The highly conserved Sarm proteins contain ARM and SAM protein-protein 
interaction domains as well as a TIR domain, and require all of these for proper 
regulation of WD.  In C. elegans, the ortholog TIR-1 acts downstream of an influx 
of extracellular calcium to activate a MAP kinase pathway82.  Similarly, in mice, 
SARM1 acts upstream of a MAP kinase cascade activated by axon injury45. 
Recently, another potent regulator of WD was discovered.  Mutants of 
Drosophila hiw, and later its mouse ortholog Phr1 were shown to protect severed 
axons to an extent similar to Wlds and dsarm/Sarm188,89.  Hiw and PHR1 are part 
of a highly conserved family of E3 ubiquitin ligases with prominent roles in axon 
guidance, synapse formation, and axon regeneration91.  In addition to protein 
degradation, Hiw family members govern these processes through signaling 
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events and cytoskeletal rearrangement96.  Interestingly, Hiw family proteins have 
also been shown to negatively regulate a MAP kinase cascade in various 
contexts.  In WD, it is proposed that Hiw and PHR1 regulate levels of NMNAT 
enzymes, which are thought to act as survival factors for axons88,89. 
dsarm and hiw both endogenously regulate the degeneration of severed 
axons.  Do these genes also regulate dendrite degeneration?  Drosophila 
dendritic arborization neurons (da) extend large, complex dendritic branches and 
are an excellent system to use to address this question.  The da neurons are 
classed I-IV based on the complexity of their branches1.  Class III and IV neurons 
have the most complex branch patterns, and reside in the larval body wall 
allowing direct visualization of their dendrites in live, intact animals.  Class III da 
neurons respond to gentle touch, and do not regenerate ablated dendrites73,78.  
Class IV da neurons respond to noxious stimuli including heat and UV light, and 
regenerate both dendrites and axons if they are ablated76,78.  Using these CIII 
and CIV da neurons, we provide evidence that both dsarm and hiw are required 
for dendrite degeneration after injury.  We also use time-lapse recording of 
dendrites expressing GCaMP to investigate the role of these genes in dendritic 
and mitochondrial calcium handling after dendritic injury.  Finally, we show that in 
hiw mutants, protection is branch-specific, distinguishing it from the protection 
afforded by Wlds and dsarm mutants, and the protection of axons by all three. 
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Results 
Genes required for Wallerian degeneration also govern dendrite 
degeneration after injury 
Upon injury, axons undergo a stereotyped sequence of degeneration and 
clearance called Wallerian degeneration (WD)25.  The mutant protein slow 
Wallerian degeneration (WLDs) strongly inhibits this process in both axons and 
dendrites57.  Recently, two endogenous regulators of WD were described that 
robustly prevent injury-induced degeneration in Drosophila axons: dsarm and 
hiw.  We therefore wanted to determine if these genes also govern dendritic 
responses to injury.  To assay dendritic injury, ppk-Gal4 was used to label class 
IV multidendritic neurons in the Drosophila larval body wall.  The dendrites of 
these sensory neurons were injured with a pulsed-UV laser and imaged 
immediately after injury and 24hrs later.  The ImageJ plugin NeuronJ was used to 
trace and analyze the images; tracings appear below their respective images 
(Figure III-1 A-D).  As previously shown by Tao and Rolls, injured WT dendritic 
branches degenerate and are cleared by 24hrs after dendriotomy (Figure III-
1A)57.  WLDs strongly protects severed dendritic branches, with greater than 70% 
of the total branch length remaining at 24hrs (Figure III-1B).  The injured 
dendrites remaining at 24hrs are somewhat simplified, having lost a portion of 
their terminal branches.  Mutations in an endogenous regulator of axon 
degeneration, dsarm, also protected dendrites after injury to a degree equivalent 
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with WLDs (Figure III-1C), suggesting that endogenous regulators of WD cell-
autonomously govern neurite degeneration.   
Surprisingly, mutations in hiw, which confer protection to axons similar to 
WLDs and dsarm, afforded only 40% protection to the severed dendrites (Figure 
III-1D & E).  Interestingly, the partial protection of hiw mutants seems to be cell 
specific, as only 60% of the ablated cells had protected dendrites as compared 
with 100% of WLDs and dsarm mutant cells (Figure III-1F).  If only those hiw 
mutant cells showing protection are analyzed, the dendrite protection seen is on 
par with WLDs and dsarm mutants (Figure III-1G).  This result suggest that the 
partial protection of hiw mutant cells occurs on a cell-by-cell basis and results in 
an all-or-none phenotype.  Taken together, these data argue that endogenous 
pathways that govern axon degeneration also govern dendrite degeneration after 
injury.  
Class IV da neuron dendrites are capable of regenerating after sustaining 
an injury, unlike other larval sensory neuron dendrites, such as those of CIII da 
neurons78.  To determine if genes required for WD govern dendrite degeneration 
in a different neuronal subtype that has different regeneration responses to 
injury, we examined whether WLDs, dsarm, and hiw mutants also protect injured 
dendrites in class III multidendritic sensory neurons.  Class III da neurons also 
reside in the larval body wall and are marked by the 19-12-Gal4 driver.  Their 
dendrites consist of long, microtubule-enriched primary branches (green in the 
tracings) and short, actin-rich sensory filopodia or spikes that originate from and 
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line the primary branches (magenta in the tracings).  To assay WD genes in the 
degeneration of CIII dendrites, primary branches were ablated close to the cell 
bodies.  Images and tracings of the branches were recorded as above.  In WT, 
branches degenerated and were cleared by 24hrs after ablation, as occurs with 
CIV cells (Figure III-2A).  Also similar to CIV cells, Wlds and dsarm mutant 
branches failed to degenerate (Figure III-2B and III-2C).  hiw mutant branches 
were also preserved, but to a lesser extent than WLDs or dsarm, or even hiw CIV 
cells as only ~30% of CIII cells showed preservation of dendritic branches 
(Figure III-2D and III-2E).  Interestingly, the persistent CIII branches in all 
genotypes show a different pattern of preservation than the CIV branches.  The 
primary branches were largely intact, and did not show a simplification as do the 
CIV branches (Figure III-2F).  The sensory filopodia/spikes, however, were 
greatly reduced in number, though not average length, 24hrs after injury (Figure 
III-2G, III-2H).  Surprisingly, hiw mutants, when the branches failed to 
degenerate, had significantly more spikes preserved than WLDs or dsarm.  
Overall, these results argue that WD genes operate in different neuronal cell 
types to govern dendrite degeneration. 
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Injury induces intra-dendritic calcium transients 
The influx of extracellular calcium has been shown to be both necessary 
and sufficient for normal axon degeneration in vitro and in vivo46.  Upon 
transection of axons, intra-axonal calcium rapidly increases and then returns 
toward baseline118.  This initial burst in axonal calcium level may initiate WD, as 
pharmacologically blocking L-type calcium channels or chelating extracellular 
calcium prevents degeneration.  Recently, WLDs was shown to attenuate the rise 
in axonal calcium after a laser ablation injury, likely by increased mitochondrial 
calcium buffering118.  Calcium handling in dendrites is different than axons; 
calcium transients represent the main signal found in post-synaptic or sensory 
activation of dendrites whereas they contribute little to the action potentials of 
normal extra-synaptic axonal function12,13.  We therefore wanted to determine 
whether dendrite injury also results in calcium transients upon injury as in axons.  
To do this, we expressed GCaMP6S in CIV da neurons with the ppk-Gal4 
promotor.  Co-expression of myr-td-Tomato allowed visual confirmation of 
dendriotomy.  Data were collected by time-lapse confocal microscopy and mean 
ΔF/F0 values per time point were plotted.  In resting WT cells, intra-dendritic 
calcium, as imaged with GCaMP6S, is maintained at a steady and low level 
(Figure III-3A).  Laser ablation of a dendritic branch near the cell body resulted in 
a robust GCaMP signal in the branch both proximal and distal to the cut (Figure 
III-3B).  This spike in intra-dendritic GCaMP signal was transient, and levels 
returned toward baseline levels as before the injury.  In Figure III-3C, GCaMP 
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tracings of the branch distal to the cut (grey) and the mean (red) are plotted 
versus time.   
 
Dendritic calcium transients upon injury in Wallerian degeneration mutants 
To determine whether dendritic GCaMP signals are attenuated by WLDs 
as in axons, we expressed WLDs or a catalytically inactive form of WLDs (WLDs-
dead) that was shown to be inactive in both axon protection and the attenuation of 
a GCaMP spike after axon injury118.  Surprisingly, unlike axonal GCaMP spikes, 
dendrites expressing WLDs showed no difference in peak signal or time to return 
to baseline than WLDs-dead in the dendrite distal to the cut.  These results could 
indicate differences between axons and dendrites in the way calcium is handled, 
or reveal differences in degeneration between these two cellular compartments.  
We next wanted to determine if endogenous WD genes affect calcium transients 
in dendrites after injury.  Dendrite branches of WT and dsarm MARCM clones 
expressing myr-td-Tomato and GCaMP6S were laser ablated and imaged.  The 
resulting ΔF/F0 GCaMP tracings showed no difference between WT and dsarm in 
peak signal or return to baseline (Figure III-3E), suggesting that the dendrite 
protection seen in dsarm mutants does not depend on the attenuation of a 
calcium spike upon injury.  Similarly, hiw mutant dendrites had comparable peak 
and return to baseline ΔF/F0 values as hiw / + controls (Figure III-3F).  These 
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results together suggest that both dsarm and hiw act downstream or 
independently of a calcium spike after dendrite severing. 
 
Mitochondrial calcium transients upon dendrite injury in Wallerian 
degeneration mutants 
Mitochondria are important regulators of intracellular and intra-axonal 
calcium levels, and have been implicated to be the subcellular compartment 
where WLDs operates36,118.  Since extracellular calcium influx is required for WD, 
and since mitochondria buffer and store calcium, we reasoned that mitochondrial 
calcium levels could change after dendrite injury and that mutants that prevent 
WD could alter that process.  To investigate calcium dynamics in mitochondria in 
vivo, we created a GCaMP5a that is targeted to the mitochondrial matrix via the 
mitochondrial import sequence from human cytochrome C oxidase subunit VIII.  
This mitoGCaMP was expressed in CIV da neurons together with myr-td-Tomato 
to visualize dendriotomy and analyzed as above.  In WT cells, mitoGCaMP 
labelled mitochondria in the dendrites, cell bodies, and axons of CIV da neurons 
(Figure III-4A).  Upon laser injury to a dendrite close to the cell body, mitoGCaMP 
fluorescence rapidly increased in mitochondria throughout the cell and returned 
toward baseline in a manner similar to soluble GCaMP6S (Figure III-4B).  
Additionally, the dendritic mitochondria appeared to shrink after injury; a 
morphological change that has been reported in axons117. 
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To determine if mutants affecting WD also alter mitochondrial calcium 
dynamics after injury, we expressed either WLDs or WLDs-dead as well as 
mitoGCaMP and myr-td-Tomato in CIV da neurons.  Upon laser injury, there was 
a spike in mitoGCaMP fluorescence and a subsequent return to baseline (Figure 
III-4C). No difference was observed between the WLDs and WLDs-dead groups in 
ΔF/F0 peak and return to baseline values (Figure III-4C).  Similarly, there was no 
difference between hiw mutants and the heterozygous control animals (Figure III-
4D).  These results suggest that WD mutants may not alter mitochondrial matrix 
calcium handling after injury to dendrites.   
 
hiw mutants reveal cell-autonomous branch-specific degeneration of 
dendrites 
The partial protection afforded to dendrites by a hiw mutant is at odds with 
the data for axon degeneration in flies and mice88,89.  Robust protection of axons 
after injury in hiw mutants has been reported for nearly the entire lifespan of the 
fruit fly (~50 days) and strong (but incomplete) protection for at least 10 days in 
transected mouse sciatic nerve.  Additionally, cell-to-cell variability at a time point 
as early as 24hrs in any system has not been reported for hiw mutants.  We 
therefore sought to investigate these discrepancies further.  We took advantage 
of the fact that the hiwΔN allele is homozygous viable119, and injured dendritic 
branches on adjacent CIV da neurons.  All of the branches, as well as the axons, 
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were severed in four neighboring cells (Figure III-5A, top).  Interestingly, some 
dendritic branches, but not others failed to degenerate in each cell, suggesting 
that degeneration is branch-specific rather than cell specific (Figure III-5A, 
bottom).  The branches were severed in a clockwise fashion starting at the 12 
o’clock position in each cell to ascertain if a recent prior injury to the cell could 
influence the degeneration of other branches.  As no clear pattern emerged in 
the order of branch preservation, the degeneration appears to not be influenced 
by a previous injury.  All the severed axons remained, similar to what has been 
reported previously in other neurons103.  It is possible that length of a dendrite 
branch determines whether it will degenerate normally in this mutant background; 
therefore branch length was quantified and related to degeneration status.  There 
was no significant difference in the average branch length between degenerated 
and preserved branches, indicating that this possibility is not a likely explanation 
for the partial protection seen in hiw mutants (Figure III-5B). 
The hiw allele thus far used to examine dendrite degeneration after injury, 
hiwΔN, is a viable truncation that removes the N terminus of the gene.  While 
production of a truncated, and possibly partially active, protein has so far not 
been formally excluded, phenotypes such as neuromuscular junction overgrowth 
and a robust defect in axon degeneration after injury have been reported with this 
allele120.  However, we wanted to test other alleles to exclude such possibilities.  
Recently, many alleles of hiw were recovered in a forward-genetic screen for 
axon degeneration mutants103.  We therefore tried an additional allele, hiw587, 
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which encodes an early stop in the gene.  This allele is homozygous lethal, so we 
used MARCM to generate clones labelled by ppk-Gal4.  MARCM also allowed us 
to test the cell autonomy of hiw587 to suppress degeneration in CIV da neuron 
dendrites.  Clones were identified and all dendrite branches, as well as axons, 
were severed near the cell body and imaged as above.  In the MARCM clones, 
some dendrites failed to degenerate, and branches showing protection were 
preserved to a level equivalent with hiwΔN (Figure III-5C and D).  In all cases, the 
severed axons were preserved by 24hrs (Figure III-5C and D).  Similar results 
were obtained with a third allele, hiw275, which also encodes an early stop in the 
gene (data not shown).  Altogether, these results indicate a cell-autonomous role 
for hiw in the branch-specific degeneration of dendrites after injury.   
 
Discussion 
In this study, we found that endogenous regulators of axon degeneration 
also regulate the degeneration of injured dendrites.  Surprisingly, the 
preservation of the complex and dynamic dendritic structures of CIV and CIII da 
neurons revealed differences between WLDs/dsarm and hiw.  Several mutations 
in hiw provided cell-autonomous but seemingly branch-specific degeneration in 
CIV dendrites, suggesting that this process could be stochastic or delayed in 
these backgrounds.  We also found that dendrites, like axons, experience a large 
calcium transient in response to injury.  In contrast to that seen in axons, WLDs 
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does not lessen the transient; nor do dsarm or hiw mutants.  A similar pattern 
was observed with a mitochondrially-targeted GCaMP5a, suggesting that 
regulating mitochondrial matrix calcium handling as can be assayed by GCaMP 
after injury is not a mechanism of dendrite protection for either Wlds or hiw. 
Protection of axons from Wallerian degeneration has been observed for 
some 25 years, however only recently endogenous regulators of this process 
have been identified.  Mutations in dsarm/Sarm1 and hiw/Phr1 robustly protect 
axons after axotomy.  We show that this protection extends to dendrites in 
Drosophila sensory neurons.  Two different classes of dendritic arborization 
neurons with different injury-induced regeneration responses were tested.  Class 
IV da neurons robustly regenerate their dendrites (and axons) after laser ablation 
while class III da neurons do not regenerate an injured dendrite.  However, our 
analyses show that degeneration responses to injury are equivalent between 
these two classes of neurons, suggesting that the degeneration and regeneration 
responses to injury operate through distinct mechanisms. 
In both classes of neurons, we observed a simplification of preserved 
dendrites after injury.  In mutant CIV da branches, terminal branches were lost 
while the majority of the dendritic structure was maintained.  In mutant CIII da 
branches, actin-rich spikes were diminished in number while the microtubule-rich 
primary dendrites were completely preserved.  Comparing these two patterns of 
preservation could indicate that labile, actin-based branches are less preserved 
and may be the first structures to degenerate after injury.  The loss of these 
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branches could also be explained by a change in branch dynamics, resulting in 
an imbalance between extension and retraction.  CIII spikes are extremely 
dynamic in most larval stages, and in singed mutants a perturbation in dynamics 
leads to decreased spike numbers121. Interestingly, in some cases with all three 
mutants, dynamic spikes could be observed 24hrs after injury, suggesting that 
dynamics are preserved after injury and that an imbalance in extension/retraction 
could participate in spike loss (scan for QR code at end of paragraph for an 
example).  Many termini of CIV da neurons are also actin-rich, dynamic, and lack 
microtubules122.  Microtubule invasion into these labile structures stabilizes the 
termini, whereas retraction typically occurs if this invasion/stabilization fails to 
occur.  Altogether, these results suggest that microtubule-based structures are 
protected in WD mutant dendrites while actin structures are largely lost, whether 
through bone fide degeneration or through dynamic imbalance.  
 Preserved dynamics in dsarm896-protected class III dendrite       
24hrs after ablation. 
Extracellular influx of calcium into an injured axon has been shown to be 
necessary and sufficient for axon degeneration46.  We and others have 
previously shown that there is a large spike in axonal calcium upon injury118,123.  
WLDs reduces this spike, likely through enhanced mitochondrial buffering of 
calcium that leads to an attenuation of the degeneration signal.  Here, we show 
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that dendrites also have a large injury-induced calcium spike.  We also show that 
dendrite injury results in a calcium spike within mitochondria.  Puzzlingly, though 
WLDs protects both dendrites and axons, it did not diminish the dendritic calcium 
transients.  This discrepancy could be due to differences between calcium 
handling in axons versus dendrites.  In axons, extra calcium is largely cleared by 
mitochondria and the passive sodium/calcium exchanger124.  Accordingly, 
mitochondria accumulate in axonal regions of high metabolic activity, calcium 
influx, and sodium influx (which causes the Na/Ca exchanger to import calcium), 
such as at nodes of Ranvier125.  Dendrites, however, rely almost exclusively on 
glycolysis and the plasma membrane calcium ATPase to clear the dendroplasm 
of excess calcium18.  Therefore, enhancing mitochondrial calcium buffering may 
not alter dendritic responses to large injury-induced calcium spikes as it does in 
axons.   
It will be important to test the mitochondrial calcium responses to axon 
injury with these mutants.  Interestingly, higher levels of intra-mitochondrial 
calcium have been correlated with decreased mitochondrial motility125.  
Mitochondrial motility is also suppressed upon axon injury, but in WLDs-
expressing axons mitochondrial motility is maintained118.  The interesting link 
between mitochondrial motility, calcium buffering, and axon protection could, 
therefore, distinguish axon and dendrite degeneration. 
dsarm and hiw mutants also do not change dendritic calcium responses to 
injury.  An interpretation of these results is that these genes act downstream of a 
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degeneration-inducing calcium signal.  In C. elegans, the dSarm ortholog Tir-1 
acts downstream of a calcium signal in a pathway that determines left/right 
asymmetry in a pair of neurons82.  Additionally, SARM1 in mouse neurons was 
proposed to function downstream of calcium-induced increase in mitochondrial 
reactive oxygen species production126.  Hiw, on the other hand, has been 
implicated in the regulation of several calcium-signaling proteins including AMPA 
receptors, adenylate cyclases, and TRPV191.  However, since calcium transients 
are not changed in hiw mutants, it is unlikely that Hiw acts upstream of these 
calcium regulating proteins to prevent degeneration.  Therefore, dSarm and Hiw 
likely act downstream or independently of calcium spikes in neurite degeneration. 
Hiw is a highly conserved E3 ubiquitin ligase with roles in axon and 
synaptic development.  Recently, mouse Phr1 and fly hiw were shown to be 
required for the degeneration of axons after injury88,89.  We show that hiw is also 
required for the proper degeneration of injured dendrites.  However, the 
protection afforded by hiw mutants is variable: some dendrite branches are 
preserved while others completely degenerate.  This is in contrast to axon 
protection within the same cells and with other axons tested in flies and mice.  
There are no paralogs of Hiw, but it is possible that a functional paralog 
compensates for the loss of Hiw; for example there are at least 50 identified E3 
ubiquitin ligases in the Drosophila genome127.  Ubiquitin ligase activity is the best 
studied function for the Hiw family, and the down regulation of dNmnat and 
NMNAT2 has been invoked to explain Hiw/PHR1 function in axon 
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degeneration39.  However, due to the lack of reagents to adequately detect 
endogenous dNmnat or NMNAT2, these studies rely on differences in 
overexpressed protein levels between WT and hiw/Phr1 mutant neurons after 
injury.  It remains to be seen whether endogenous dNmnat levels are increased 
in hiw mutant axons and/or dendrites upon injury. 
It is possible that the down regulation of dNmnat is not the mechanism 
Hiw uses to promote neurite degeneration.  Hiw/PHR1/RPM-1, similar to 
SARM1/TIR-1, have been placed upstream of a MAP kinase cascade by 
negatively regulating the MAPKKK Wnd/DLK/DLK-1 that then positively regulate 
their respective MAP kinase cascades91.  The resulting increase in MAPK 
signaling has been implicated in receptor trafficking, axon regeneration, and 
synapse development.  Interestingly, mutations in wnd were recently shown to 
modestly delay axon degeneration as compared with dsarm and hiw mutants88.  
It will be important to test whether mutations in wnd and downstream 
components also confer protection to injured dendrites. 
The maintenance of dendrites is critical to sustain neural connectivity and 
nervous system function.  Explicit dendritic pathology and loss is observed in 
many disease states, such as Alzheimer’s, Parkinson’s, ALS, and during 
excitotoxicity following trauma or stroke10,24,128–130.  Therefore, the ability to 
prevent pathological dendrite degeneration would be a powerful tool to combat 
functional loss in neurological disease.  Here, we reveal two endogenous 
regulators of dendrite injury in vivo.  The partial protection of injured dendrites 
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seen in hiw mutants precludes its usefulness as a drug target; yet the robust 
protection of dendrites as well as axons by dsarm mutants highlight SARM1 as 
an attractive target for drug development.  These studies, therefore, have 
revealed new roles for WD genes and reinforced the validity of SARM1 as a 
therapeutic target in the search for new treatments for neurological disease. 
 
Materials and Methods 
Fly stocks 
All fly stocks were maintained at 25°C on standard cornmeal-molasses 
agar medium.  The following strains from the Bloomington Drosophila stock 
center were used in these studies: ppk-Gal4, UAS-mCD8::GFP, UAS-
mCD4::tdTomato, UAS-GCaMP6S. UAS-mitoGCaMP5a was generated by PCR 
amplifying the full 1354bp of GCaMP5a from pGP-RSET-EcoRV-GCamp3-T302L 
R303P 7.36 (a gift from Doug Kim, Janelia Farm) and ligating it into the pJFRC7-
20xUAS-mito plasmid with NotI / Xba.   Additional lines used were:  UAS-Wlds 
and UAS-Wlds-dead 31, dsarm896, dsarm4621 68, hiw587, hiw275 103, hiwΔN (a gift from 
Cathy Collins, University of Michigan), and 19-12-Gal4 ; repo-Gal80.  
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Laser Ablation Assay and Analysis 
Early 3rd instar larvae (~96hr AEL) were collected and anesthetized with 
isofluorane.  They were then mounted in halocarbon oil-27 (Sigma) and placed 
under a coverslip with a 0.25mm silicone slotted gasket (Warner Instruments, 
Hamden, CT).  Dendritic arborization neurons were then imaged on a Zeiss M1 
upright spinning disc confocal (Intelligent Imaging Innovations, Denver, CO) and 
neurites were severed using a Micropoint laser ablation unit at 63x magnification 
(Andor Technology, South Windsor, CT).  Larvae were subsequently recovered 
on culture media, stored at 25°C for 24hrs and imaged. 
Compressed Z stack images from each time point were exported from 
Slidebook 6 (Intelligent Imaging Innovations, Denver, CO) into ImageJ (National 
Institutes of Health).  The ImageJ plugin NeuronJ (REF) was used to trace 
dendrite lengths.  Graphing and one-way ANOVA/Tukey’s multiple comparison 
test analyses were performed using GraphPad Prism 6.02.  Image composites 
were made in Adobe Photoshop CS6. 
 
Timelapse Calcium Imaging Assay and Analysis 
Wandering 3rd instar larvae were collected, anesthetized, imaged, and 
injured as described above.  For the timelapse studies, 11µm Z stacks with a 
step size of 1 µm were defined to encompass the dendrite of interest.  Frames 
were collected every 50ms (essentially without pause), with laser exposure times 
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of 250ms for 488nm and 50ms for 561nm.  The timelapse was allowed to 
proceed for 30s and then the dendrite branch was ablated with the Micropoint 
system followed by additional imaging.   
Compressed Z stacks were then analyzed using Slidebook6.  A region 
that did not contain dendrites in any time point was used to subtract the 
background.  Another region was drawn around the distal stump and the red 
channel was used to gate the dendrite.  Mean intensity of GCaMP signal within 
the gated dendrite was then analyzed.  For mitoGCaMP data, the mean 
intensities of the mitochondria, as defined by the area within the mito-Tomato 
signal, were quantified.  Data were then statistically analyzed in GraphPad Prism 
using unpaired t test. 
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Figure III-1. Degeneration of Drosophila class IV da neuron dendrites 
requires dsarm and hiw. 
Class IV dendritic arborization neurons are labelled with ppk-Gal4 driving 
mCD8::GFP.  When ablated, WT dendrites undergo degeneration, and are 
cleared by 24 hours post ablation (A).  The arrow denotes the region where the 
dendrites were ablated.  When WLDs is expressed in these neurons, ablated 
dendrites remain intact (B).  In dsarm (C) or hiw (D) mutants, ablated dendrites 
also fail to degenerate.  The level of protection in hiw mutants is significantly less 
than with WLDs or dsarm mutants (E).  All cells tested with WLDs and dsarm 
mutants showed protected dendrites, while only ~60% of hiw mutant cells 
showed protection (F).  There are equivalent levels of protection between WLDs, 
dsarm mutants, and those hiw mutants showing protection (G).  Error bars = SEM  
**** p<0.0001  ** p<0.01   * p<0.05 
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Figure III-2. Degeneration of Drosophila class III da neuron dendrites 
requires dsarm and hiw. 
Class III dendritic arborization neurons are labelled with 19-12-Gal4 driving 
mCD8::GFP.  When ablated, WT dendrites undergo degeneration, and are 
cleared by 24 hours post ablation (A).  The arrow denotes the region where the 
dendrites were ablated.  When WLDs is expressed in these neurons, ablated 
dendrites remain intact (B).  In dsarm (C) or hiw (D) mutants, ablated dendrites 
also fail to degenerate.  The level of primary dendrite protection in hiw mutants is 
significantly less than with WLDs or dsarm mutants; however if only cells showing 
protection are quantified, the levels are equivalent between WLDs and mutants of 
dsarm and hiw (E).  Total mean dendritic spike lengths are greatly reduced after 
injury in all genotypes (F).  The reduction of dendritic spike length is not due to 
decreased length of individual spikes (G), but rather due to a reduced number of 
spikes (H). Error bars = SEM  **** p<0.0001  ** p<0.01   * p<0.05 
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Figure III-3. Injury-induced calcium transients in Drosophila class IV da 
neuron dendrites are not changed in WD mutant dendrites in vivo. 
Class IV dendritic arborization neurons are labelled with ppk-Gal4 driving myr-
tdTomato and GCaMP6S (A).  Ablation causes calcium transients in WT 
dendrites (B).  The arrow denotes the region where the dendrites were ablated.  
C, Plot of GCaMP ΔF/F0 values from timelapse recordings with ablation of 
individual WT dendrites (grey) and the mean (red).  WLDs expression does not 
change the mean ΔF/F0 values of injury-induced calcium transients (D).  In dsarm 
(E) or hiw (F) mutants, these transients are also not different than the control 
values.  Scan QR code for a representative video. 
 
 
  
100 
 
 
 
 
  
101 
 
 
 
 
Figure III-4. Injury-induced mitochondrial calcium transients in Drosophila 
class IV da neuron dendrites are not changed in WD mutant dendrites in 
vivo. 
Class IV dendritic arborization neurons are labelled with ppk-Gal4 driving myr-
tdTomato and mito-GCaMP5a (A).  Ablation causes calcium transients in WT 
dendritic mitochondria (B).  The arrow denotes the region where the dendrites 
were ablated.  C, WLDs expression does not change the mean ΔF/F0 values of 
injury-induced calcium transients (D).  In hiw (D) mutants, these transients are 
also not different than the control values. 
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Figure III-5. hiw mutants exhibit cell-autonomous branch-specific 
degeneration after injury. 
A, Class IV dendritic arborization neurons are labelled with ppk-Gal4 driving myr-
tdTomato.  Clockwise ablation of all dendrite branches and the axon (arrowhead) 
of four adjacent class IV da neurons.  24 hours after ablation (below), axons are 
preserved (arrowheads) but ~50% of dendritic branches degenerated and were 
cleared.  B, no difference is seen between average traced lengths just after injury 
of degenerated or preserved dendrites.  C, MARCM clone of hiw587 labelled with 
ppk-Gal4 driving mCD8::GFP.  All dendrite branches and the axon were ablated 
(arrows, ablation; arrowhead, axon).  Right, 24hrs after ablation showing 
preservation of some branches but not others, as well as an intact axon 
(arrowhead).  D, average percent of remaining dendrites (length) and axons 
(number) in hiwΔN and hiw587 mutants.  Error bars = SEM 
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Chapter IV: Discussion 
 
 
 
Endogenous regulators of Wallerian degeneration 
 
That the degeneration of a transected cellular process can be inhibited is 
remarkable.  This realization led to the concept of Wallerian degeneration (WD) 
as an active process, initiated by injury to axons and dendrites.  Though most 
neural injury is not as acute or severe as a clear transection, pathology yet 
ensues.  Many disease processes, such as in neurodegenerative diseases, result 
in the dying back of axonal processes.  This degeneration morphologically 
resembles WD and is therefore called Wallerian-like degeneration.  Examples 
include mouse models of motor neuron disease and multiple sclerosis, as well as 
diabetic neuropathy in patients131–133.  Such disease processes could activate 
WD at a low, chronic level that leads to gradual neural destruction over long 
periods of time.  The axon and dendrite protective WLDs protein has been shown 
to ameliorate pathology in some neurodegenerative disease models, including 
those mentioned above, suggesting that inhibiting WD could indeed help to 
maintain neural function and lessen disease burden.  
Expression of WLDs shows even greater protection of axons in models of 
acute injury39.  Some of these insults, such as acute multiple sclerosis attacks, 
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are transient, and inhibiting WD could give the injured cells time to recover 
without initiating degeneration.  Examples of acute axon injury include 
hypoxia/ischemia, excitotoxicity, and exposure to toxins such as taxol and 
vincristine, all of which are attenuated by WLDs  61,65,134,135. 
However, the molecular nature of how WLDs protects neurites is not 
known.  Since WLDs is not an endogenous protein, it cannot be targeted by 
pharmaceuticals.  Therefore, the identification of endogenous regulators of WD is 
of utmost importance to develop therapeutics to prevent or treat neuronal injury. 
To search for regulators of WD, I first scoured the literature for candidates 
based on their involvement in cell death pathways or their potential relation to 
dSarm/SARM1 or WLDs.  Testing of strong mutants, such as confirmed genetic 
nulls, allows genes to be excluded from having a role in WD.  In my candidate 
list, several categories with strong mutants showed no role for the caspases, 
immune signaling proteins, or calcium regulating proteins tested.  The three 
initiator caspases in Drosophila (Dronc, Strica, and Dredd, alone and in double-
mutant combinations) as well as an effector caspase (Dcp-1) were tested, as 
there are non-apoptotic roles for certain caspases in axon degeneration during 
developmental processes136.  These mutants did not alter WD, supporting 
independent pathways for these degenerative processes as previously 
suggested by Bax deletion and BCL-2 overexpression54,55. 
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SARM1 likely relays a degenerative signal via its TIR domain, a domain 
well conserved for signaling in Toll-like receptor (Tlr) pathways80,87.  Therefore, I 
tested Drosophila Tlr mutants in degeneration.    No strong phenotype was 
observed using the lines in Table II-1, however, some debris was seen with Toll2 
(18Wheeler) and Toll5 (MystProx) mutants, suggesting that they may play a role 
in glia in the clearance of degenerated axons.  Similar results and later 
independent verification of glial defects were obtained with a kayak mutant71.  
These results are consistent with reported roles for TLR4 in the clearance of 
degenerated mouse neurons in vitro and in vivo137,138.  
As the influx of extracellular calcium is necessary and sufficient for WD, 
several genes that regulate intracellular calcium were also tested.  Normal WD 
was seen in null mutants of the sole RyR, Orai, and IP3R genes in the fly, 
arguing against a role for store-operated calcium release.  This is in contrast with 
a report that axoplasmic reticulum calcium release triggers WD139.  However, this 
effect was observed with chemical inhibitors and siRNA in culture 12hrs after 
injury, as compared with 7 days in vivo with reported nulls of RyR, Orai, and 
IP3R.  Inhibition of these receptors could modulate WD to an extent, but are not 
likely to be part of the main pathway that includes dsarm and hiw. 
The conclusion that influx of extracellular calcium is involved in WD is 
largely centered on the delay in degeneration by pharmacological inhibition of L-
type calcium channels46,47.  Several Drosophila L-type calcium channel subunit 
mutants were tested in the WD assay and found to not affect the degeneration of 
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axons, but rather delayed the clearance of the axonal debris.  Interestingly, 
cacophony and ca-α1D mutants were tested neuronal cell-autonomously, which 
could indicate a role for the production of an axonal eat-me cue after 
degeneration. 
These results are in contrast with the conclusions of some studies using 
pharmacological inhibition of mammalian L-type calcium channels in vitro and in 
vivo46,47,140.  However, the calcium channel blockers used, such as nifedipine, 
could alter calcium regulation or have other roles in degeneration independent of 
L-type calcium channel inhibition.  Such an effect was observed with nifedipine in 
calcium regulation not involving L-type calcium channels in vascular smooth 
muscle141.  Additionally, there are differences between Drosophila and 
mammalian L-type calcium channels142, and these drugs have not been 
evaluated in Drosophila axon degeneration.  Nevertheless, nulls of these 
channels failed to prevent axon degeneration, suggesting that they do not play a 
major role in this process in Drosophila. 
Many of the other lines tested above are potentially not complete loss of 
function alleles, which precludes the ability to make solid conclusions of their role 
in axon degeneration.  They remain worthwhile candidates, and better screening 
techniques could investigate their role in WD further.  Novel gene targeting 
techniques such as CRISPR are vastly reducing the time and effort of gene 
deletion100.  It would not be surprising to see a genome-wide gene deletion effort 
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produce genetic nulls of most Drosophila genes, which could then be tested for 
the prevention of WD. 
I also performed a forward-genetic screen of the Drosophila 2nd 
chromosome to identify novel regulators of Wallerian degeneration.  
Unfortunately, no lines screened showed defects in axon degeneration.  This 
could be due to a number of potential issues with the screen.  The lines 
constructed could be incorrect; however the characterization of these lines as 
shown above (Figures II-5 and II-6, WT panel) makes this possibility unlikely.  
Additionally, since 82% of the lines had a homozygous lethal 2nd chromosome, 
there was likely adequate EMS-induced mutagenesis. 
Redundancy in signaling components can greatly decrease the likelihood 
of recovering strong phenotypes in a screen.  For example, if two redundant 
genes reside on different chromosomes, or even different chromosomal arms 
then mutants in these genes will not be recovered using MARCM as this system 
can only test one arm at a time.  It is possible to make MARCM clones that are 
homozygous for two different chromosomal arms, but as this requires additional 
transgenes and results in less clone induction, it would be prohibitively 
complicated in a screen setting.  An example of redundancy in Wallerian 
degeneration signaling was recently shown in the identification of a MAPK 
cascade downstream of SARM1 in axon degeneration45.  In each level of the 
pathway, from MAP kinase kinase kinase to the 3 downstream JNK paralogs, 
elimination of more than one kinase added to the axon protection phenotype.  
111 
 
The strongest phenotype, where 60% of axons were preserved at 6 days after 
axotomy, was seen with MKK7 shRNA knock-down in a MKK4-mutant 
background.  Since our screen looked at 7 days post ablation, we may have 
missed weak phenotypes in redundant genes.  We also lack the ability, in a 
screen setting, to test for redundancy other than that produced by mutants on the 
same chromosomal arm. 
One of the largest hurdles to identifying mutant phenotypes by screening 
is the throughput of the system.  The throughput and therefore likelihood of 
identifying mutant phenotypes relies heavily on screening through large numbers 
of animals.  For example, 2194 chromosome 3L arms were screened to reveal 4 
separate alleles of dsarm.  This corresponds to approximately one hit per 550 
arms tested.  In the ORN screens that identified dsarm and were performed in 
the 2nd chromosome in this work, a sustainable and sanity-preserving rate is ~10 
lines screened per day.  The screens performed were fairly laborious owing to 
the maintenance of stocks and crosses as well as the collection, ablation, fixing, 
dissecting, antibody staining, and imaging of fly brains.  Newly developed 
systems such as in the wing increase the throughput 10-20 times by eliminating 
the need to fix, dissect, and stain brains.  Additionally, so called F1 screens test 
the progeny of the EMS-mutagenized males (F1 animals) and only create an F2 
stock from those flies exhibiting the phenotype of interest.  Recovery of the 
mutant in the F2 stock is, however, difficult as less than 15% of mutants have 
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been recovered in the Freeman lab (personal communication from Tom Burdett 
and Jon Farley on 3-17-15). 
EMS surely affects separate genomic regions in distinct ways, causing 
higher mutation rates in some areas compared to others.  For example, 8 alleles 
of hiw were identified in ~1500 lines corresponding to a hit rate of approximately 
1 in 188.  Even accounting for size – Hiw is huge (~5233 amino acids) compared 
to dSarm (1637 amino acids) - this hit rate resulting in coding changes is still 
almost four times that of dsarm.  It is therefore possible that WD genes on the 2nd 
chromosome could be less affected by EMS mutagenesis and therefore fall 
below our numbers of screened chromosomes.  However, the Freeman lab has 
continued to screen the 2nd chromosome without any recovered hits, and 
numbers now total 7449 2L arms and 4013 2R arms, suggesting that there are 
few, if any, mutable non-redundant genes involved in WD on the 2nd 
chromosome. 
The identification of new roles for genes in regulating WD requires 
screening, be it by candidate or unbiased approaches.  New technology, such as 
CRISPR gene targeting could greatly accelerate this screening.  For example, 
the Drosophila 4th chromosome is typically not screened by unbiased forward-
genetic methods.  This is partly due to the lack of appreciable recombination due 
to the small size of the 4th chromosome.  The lack of recombination has 
precluded MARCM studies, as recombination is routinely used to obtain lethal 
mutants and the repressive Gal80 on a chromosome with an FRT site.  Using 
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CRISPR, it would be possible to direct the insertion of an FRT site near the 
centrosome of the 4th chromosome.  The tub-Gal80 construct could then be 
distally engineered/inserted on that FRT chromosome.  Mutants in candidate 
genes could also be engineered on the FRT chromosome to reconstitute the 
basic lines needed for MARCM.  Several interesting candidates reside on the 4th 
chromosome.  For example, both Drosophila calcium/calmodulin-dependent 
protein kinases are located on chromosome 4, and no mutants are available for 
either.  In C. elegans the CaMKII ortholog UNC-43 signals through TIR-1 (the 
dSarm ortholog) to activate a MAP kinase cascade, making CaMKII an attractive 
candidate to test in WD assays82,143.   Through advanced targeted genome 
editing techniques, it would be possible to test mutants in either or both CaMK 
genes in a MARCM setting.  Such advances, as well as continued screening 
efforts, are sure to reveal other genes that are required for axon degeneration. 
 
Dendrites  
Dendrites are the primary structures used by neurons to receive and 
process inputs in the many varied information processing networks in the 
nervous system.  This input could be from other connecting neurons or from 
sensory input that is directly sensed by the dendrites.  Sensory neurons that line 
the Drosophila larval body wall provide information about the environment, such 
as light, heat, and pressure or touch.  These da neurons extend large dendrites 
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to completely cover the larva in sensory endings.  The dendritic branches reside 
in the body wall between the basal aspect of the epidermal cells and the 
extracellular matrix.  The epidermal cells also engulf degenerating dendrites as 
occurs in developmental pruning or after physical injury to the branches.   With 
their superficial localization and extensive dendritic arbors, the multidendritic da 
neurons provide an ideal model to study responses to dendrite injury. 
Dendrites rival axons for their size and diversity of structure; some can 
account for greater than 80% of the cell surface such as in dentate granule 
neurons4.  Often containing complex branching structure, several features 
distinguish them from axons.  Dendrites have a mixed polarity of microtubules, 
whereas axonal microtubules are plus-end out.  Within dendrites, all cellular 
organelles such as mitochondrial, rough endoplasmic reticulum, polyribosomes 
and Golgi outposts can be found, while axons typically only contain mitochondria.  
Intrinsic calcium homeostasis mechanisms are also different between these two 
cellular compartments.  Axons rely on mitochondria for calcium buffering, while 
dendrites utilize membrane-bound ATPases that are fueled primarily by 
glycolysis rather than mitochondria.   
The finding that WLDs does not attenuate a calcium spike after sensory 
dendriotomy also differs from that seen in motor axons118.  This difference could 
in fact be due to the differences in calcium handling between these two 
compartments.  For example, if WLDs primarily works primarily by enhancing 
mitochondrial calcium buffering, then it may not be expected to affect the calcium 
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buffering in dendrites which does not rely on mitochondria as in axons.  It could 
also be due to differences between motor and sensory cell types.  Though a 
calcium transient was observed in the axons after dendriotomy, it remains to be 
seen whether calcium transients are altered by WLDs or dsarm and hiw mutants 
in sensory axons or motor neuron dendrites after injury in vivo.  It also remains to 
be seen whether WLDs, or mutations in dsarm or hiw alter axoplasmic and 
mitochondrial calcium transients after axonal injury.  If WLDs allows mitochondria 
to more efficiently buffer calcium, then either increases or decreases might be 
observed in mitochondrial matrix-targeted GCaMP signal depending on the 
mechanism used.  For example, if WLDs increases the ability to store calcium as 
an insoluble conjugate with inorganic phosphate144,145, a reduction in GCaMP 
signal might be observed.  Conversely, if WLDs simply allows the level of matrix 
calcium to increase without forming the mitochondrial permeability transition 
pore146, then increased GCaMP signal would be observed.  Matrix calcium levels 
are, however, remarkably stable147, and no change in calcium transients might 
reflect efficient clearance from this compartment as well. 
Dendrites and axons are both extreme extensions of the neuronal cell 
body that are designed to transmit signals.  They also degenerate after injury, 
and it seems that the degeneration of both cellular compartments is due to a 
shared signaling pathway.  This pathway is inhibited by exogenous expression of 
the WLDs protein, as well as by mutations in dsarm and hiw.  Yet several 
mutations in hiw that robustly protect axons confer only partial protection of 
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dendrites that is branch-specific.  The fact that some branches are preserved 
while others completely degenerate indicates that there are intrinsic differences 
between individual branches of the same neuron.  As the degeneration of certain 
branch is not influenced by a prior injury (Figure III-5A), these differences are 
likely present even before the injury.  Branch-specific changes in dendrites have 
recently been described, and are associated with differential input affecting 
calcium transients and plasticity in learning paradigms148,149.  These changes, 
then, are in response to exogenous input, and are not engendered by intrinsic 
differences between dendritic branches.  The branch-specific degeneration 
revealed by hiw mutants seems unique to dendriotomy. 
How could dendritic branches differ in hiw mutants?  Hiw family proteins 
regulate many processes and pathways in neurons.  For example, Hiw/Phr1 has 
been shown to interact with and regulate the cytoskeleton as well as regulate 
different signaling pathways, potentially accounting for branch-specific 
differences91.  Markers showing microtubule polarity such as the plus-end binding 
protein EB1 as well as markers for organelles such as mitochondria and Golgi 
outposts should be examined in the hiw mutant backgrounds.  Variances from 
the wild type patterns might indicate how different branches in these mutant 
backgrounds could differ from one another, leading to mechanistic 
understandings of dendrite degeneration.  Perturbations in signaling pathways 
regulated by PHR1, such as the tuberous sclerosis complex and BMP/Smad91, 
can also be evaluated in the hiw mutants.  There are no known paralogs of either 
117 
 
hiw or Phr1, but certainly functional paralogs could operate in dendrites or axons 
after injury.  Perhaps screening efforts will uncover such a gene.   
Hiw family proteins down regulate many other proteins through their 
function as E3 ubiquitin ligases.  It is possible that in the context of injury, Hiw 
also down regulates degeneration-related proteins such as dNMNAT or other 
novel targets.  The concept of a role for the ubiquitin-proteasome system (UPS) 
in axon degeneration was first brought about when VCP was found to interact 
with WLDs.  However, manipulations of the UPS such as with chemical inhibitors 
has little effect on axon degeneration.  And while the UPS is required for aspects 
of developmental dendrite pruning in class IV da neurons, hiw mutants do not 
have pruning defects, suggesting that these processes are distinct136,150.   
Interestingly, mutants in hiw were recently recovered that are thought to 
eliminate or mutate the RING domain and therefore E3 ligase activity103.  These 
mutants dominantly inhibit axon degeneration, suggesting that Hiw’s E3 ligase 
function is required for degeneration.  If these mutants bind to substrates, but do 
not mark them for degradation, then they could potentially be used to 
biochemically identify the substrates that are down regulated during axon and 
dendrite degeneration.  It will be interesting to see whether these mutants also 
dominantly inhibit dendrite degeneration after injury.   
Is the difference in degeneration between dendritic branches in hiw mutant 
cells due to some simply degenerating slower than others?  In mouse, Phr1-/- 
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axons are robustly protected but to a lesser extent than with WLDs or Sarm1-/- at 
the same time points in vitro and in vivo89.  As sensory dendrites in Drosophila 
degenerate by 12hrs after ablation, looking at earlier time points could mirror the 
mouse data.  However, the protected branches that remain show equivalent 
protection to both WLDs and dsarm mutants.  If degeneration were simply 
delayed, then all branches might be expected to show similar levels of 
degeneration instead of the all-or-nothing pattern observed.  It would be 
informative to take these studies to longer endpoints in all mutant backgrounds.  
It would be possible to extend the time course by ablating the dendrites earlier, or 
possibly by ablating adult sensory dendrites that are found on the abdomen of 
the fly.  By looking at later time points, we might be able to discover differences 
in the levels of protection in severed dendrites between these mutants. 
   
Towards an inhibitor of SARM1 proteins 
The ultimate goal of these investigations is the identification of targets that 
can be pharmaceutically modulated to lessen or prevent disease.  So far, WLDs 
has shown promising levels of axon and dendrite protection in several disease 
and toxicity models, including in human cell culture.  As the mechanism that 
WLDs employs remains elusive, it is difficult to design therapies that mimic WLDs.  
Hiw/PHR1 is a poor target due to its partial protection of dendrites (this 
study), and its involvement in other important cellular functions such as the 
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regulation of ion channel levels91.  Conversely, dSarm/SARM1 has several 
qualities that make it an attractive target.  Sarm1-/- mice are viable and healthy, 
with little or no developmental or degenerative phenotypes known.  The only 
strong phenotype observed in Sarm1-/- mice is the failure of axon degeneration 
after injury68.  The Sarm proteins are therefore potential candidates for inhibition 
by therapeutics.  In advance of the development of such drugs, our lab and 
others are currently investigating Sarm1 null mice in various neurodegenerative 
disease models.   
Toll/interleukin-1 receptor (TIR) domains are conserved signaling motifs in 
TLRs that link receptor dimerization with downstream signaling80.  SARM1 
contains a TIR domain, which has been shown to be required for axotomy-
induced degeneration87.  In the same study, SARM1 proteins were shown to 
dimerize, which could lead to activation of the TIR domains.  Inhibition of TIR 
domain signaling has been demonstrated using peptide mimics of the TLR4 TIR 
domain BB loop that are thought to interfere with TIR dimerization and 
downstream signaling151,152.  To see if this strategy could be used to inhibit 
SARM1, I designed peptides analogous to those used in the inhibition of TLR4 
signaling.  I first modeled the tertiary structure of the mouse SARM1 TIR domain 
using two different programs: Phyre2 and Jpred3.  The results appear in 
Appendix I.  Using these models, I identified the conserved BB loop, which differs 
in only 2 amino acids between mouse SARM1 and fly dSarm (2 lysines in mice 
vs. 2 arginines in flies; both are positively charged amino acids).  The sequence 
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encompassing this loop from SARM1 was used to identify the peptide sequence: 
DVEKLEAGKF. 
Small peptides can be extremely labile in neurons due to the 
preponderance of neuronal endopeptidases.  The retro-inverso approach has 
been used to stabilize small peptides within neurons, greatly extending their half-
lives153.  Retro-inverso peptidomimetics utilize D-amino acids in reverse order in 
the peptide instead of the L enantiomers used in nature.  Using the reverse order 
of the amino acids mitigates the effect of the inverted chirality, maintaining the 
spatial organization of amino acid side groups while inverting the order of the 
peptide bonds.  This arrangement allows for approximate preservation of peptide 
structure while conferring resistance to endopeptidase degradation.  I therefore 
chose to employ the retro-inverso strategy in the design of the SARM1 
peptidomimetic. 
A good inhibitor should be specific for and have adequate access to the 
target protein.  It is not known if SARM1 works within axons to promote 
degeneration, but it has been observed to be elevated in injured axons154.  Also, 
WLDs protein is able to prevent axonal degeneration if transduced directly into 
the axon up to several hours after axotomy155.  SARM1 is thought to be an 
intracellular signaling protein, and thus drugs with access to the neuronal 
cytoplasm are likely able to interact with and inhibit SARM1.  Cell-penetrating 
peptides (CPPs) are short amino acid sequences with the ability to traverse 
membranes and even carry proteins and other conjugated structures with them 
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through the membrane156.  CPPs, such as those derived from HIV TAT and the 
Drosophila Antennapedia proteins, have been used to deliver peptide inhibitors 
of JNK into neurons157.  I thus designed the SARM1 inhibitor to contain the TAT 
sequence that permits cellular uptake (underlined); the final sequence of the 
retro-inverso CPP became: FKGAELKEVDPPRRRQRRKKRG. 
I tested the SARM1 CPP in dorsal root ganglia (DRG) cultures.  While 
neither of the 3 concentrations tested prevented axotomy-induced degeneration 
by 24hrs after axotomy, as seen in Sarm-/- DRG, there was a dose-dependent 
increase in the amounts of debris remaining (Appendix I).  This could indicate a 
small delay in degeneration with the CPP, although testing a scrambled version 
of the CPP would be required to conclude that result.  Further studies including 
testing the L-amino acid version of the peptide may provide a useful starting point 
in the development of a SARM1-based therapeutic. 
 
Remaining Questions 
What constitutes the signaling pathway(s) that enact Wallerian 
degeneration?  Sarm1 was recently shown to act upstream of a MAP kinase 
cascade that involves several MAP kinases leading to activation of JNK1/2/3 and 
resulting in energy deficit after axotomy45.  It seems plausible that energy deficits 
could lead to unregulated and fulminant calcium influx resulting in the 
catastrophic granular fragmentation of axons long observed in the WD field.  
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Does this progression also occur in dendrites?  Certainly, calcium dysregulation 
has been linked to dendrite pathology, especially in the context of excitotoxicity24.  
In light of the differences in calcium handling between axons and dendrites 
discussed above, the final outcome of degeneration may proceed via 
independent mechanisms in these two cellular compartments. 
Independent mechanisms are also suggested by the differential protection 
afforded by hiw mutants in dendrites compared to axons.  Where does hiw fit into 
the pathway?  Hiw/PHR1 is thought to regulate dNMNAT/NMNAT2, a proposed 
axonal survival factor, though this has not been shown directly in axotomy or at 
all in dendrites.  Also, the down regulation of over-expressed NMNAT2 occurs 
very soon after axotomy, yet WLDs can prevent WD even when transduced 4hrs 
after axotomy33,155.  It remains to be seen whether Hiw/PHR1 can regulate 
endogenous NMNAT proteins and whether this is indeed the trigger for 
degeneration in axons and dendrites. 
If the trigger for WD is a decrease in NMNAT levels and Hiw/PHR1 
regulate this directly, then they should be upstream or in parallel to Sarm 
proteins.  When the N-terminus of SARM1 is deleted but the SAM and TIR 
domains remain, this protein acts as a dominant active and induces the 
degeneration of axons and cell bodies in the presence or absence of 
endogenous SARM187.  Testing whether Phr1 mutant or WLDs expressing 
neurons are rescued from this gain of function protein could help delineate 
whether PHR1/NMNAT2 lie upstream of SARM1.  In fact, in ORNs, WLDs can 
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suppress the axon degeneration caused by this activated dSarm (my 
unpublished results).  This suggests that WLDs acts downstream of SARM1 
activation to prevent WD.  Similarly, it is possible that, assuming WLDs 
substitutes for endogenous NMNAT activity, that SARM1 lies upstream of the 
NMNAT activity that preserves axonal integrity.  Further characterization of the 
suppression of activated SARM by WLDs could lead to insights into the 
mechanism and pathway(s) operating in WD.   
It would also be possible to design suppressor screens of this gain of 
function SARM1 to search for genes downstream of SARM1 in this form of 
degeneration.  For example, expressing the activated dSarm (dSARM SAM-TIR) 
in ORN MARCM clones causes axon degeneration and kills the neurons.  By 
simply modifying the ORN degeneration screen described in Chapter 2 above so 
that the clones also express dSarm SAM-TIR, one could screen for suppressors 
by simply looking for intact axons – no ablation required.  The Drosophila X 
chromosome could be interrogated in an even simpler scheme by using attached 
X.  The attached X chromosome allows male flies to inherit their X chromosomes 
from their fathers.  In this way, males could pass the mutagenized X 
chromosomes to their male offspring expressing dSarm SAM-TIR in all neurons, 
which normally kills the animal.  Loss-of-function suppressors of dSarm SAM-TIR 
could then be identified by the presence of male flies in the progeny that can 
survive despite expressing activated dSarm. 
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Finally, the activated SARM1 could be used to screen for chemicals that 
inhibit its function.  For example, cells lines integrated with an inducible SARM1 
SAM-TIR could be exposed to FDA-approved drugs (or any drugs) in culture.  
Induction of SARM1 SAM-TIR would then kill any susceptible cells, while those 
that remain would indicate candidate inhibitors of SARM1 signaling.  In this way, 
drugs may ultimately be identified that can prevent SARM1 signaling, which 
would make them interesting candidates to test in the context of 
neurodegenerative diseases. 
Is this degeneration pathway specific to neurons?  All cells can be injured.  
Is the reason that we are studying WD in neurons simply because of their hyper-
extended processes?  Intriguingly, WLDs expression was shown to improve 
glucose tolerance in type I and II diabetes models in mice158.  Additionally, most 
of the signaling functions attributed to hiw family members were originally found 
in human cancer cell lines, and expression of the human ortholog MYCBP2 was 
detected in all tissues159.  In C. elegans, the dsarm ortholog tir-1 is proposed to 
signal downstream of epidermal injury or fungal infection to activate a MAP 
kinase cascade, similar to that recently described for axon degeneration160.  
Interestingly, I observed that knockdown of dSarm in glia resulted in a strong 
engulfment phenotype with debris remaining 2 weeks after axotomy (Appendix II, 
unpublished results).  These results suggest that dSarm works in glia to drive the 
engulfment of axonal debris after axotomy.  Altogether, these data suggest that 
dSarm could act in other non-neuronal cell types after injury.   
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To begin to test this idea further, I made MARCM clones in Drosophila 
tracheal cells and laser ablated their cellular processes. (Appendix III).  Trachea 
are comprised of epithelial cells that constitute the Drosophila respiratory 
organ161.  These cells extend cellular processes reminiscent of neurites, and 
terminal branches can be completely severed as with axons or dendrites.  Both 
wild-type and dsarm896 clones have inconsistent degeneration of the tracheal 
branches at 24hrs, precluding a comparison at this time point.  Whether or not 
these cellular processes have a degeneration program akin to neurons may yet 
be discovered by further study of tracheal cells in these mutant backgrounds.  It 
will be interesting to learn if Wallerian degeneration is indeed a conserved and 
universal cellular process or whether it exists solely in the domain of neurons. 
 
Concluding Remarks 
In this study, I have sought to understand the process of Wallerian 
degeneration.  I describe screening strategies to find endogenous regulators of 
WD and highlight several genes required for the efficient processing of axonal 
debris and its clearance, as well as candidates that are not involved in axon 
degeneration.  I then show that endogenous regulators of axon degeneration are 
also required for the injury-induced degeneration of dendrites in Drosophila.  In 
doing so I found unexpected differences between injury responses in axons and 
dendrites, which may reveal interesting differences between these neuronal 
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processes.  I also found unexpected differences in dendrite degeneration 
between mutants of Wlds/dsarm and hiw.  My preliminary investigations into 
developing a SARM1 inhibitor as well as examining WD in non-neuronal cells 
have provided a framework to further these avenues of research. 
The study of WD is of great importance in the fight against 
neurodegenerative disease, a concept not lost on the founding father of the field, 
Augustus Waller.  I believe that the delineation of pathways and mechanisms 
operating after injury and in disease will ultimately lead to our ability to decrease 
the suffering inflicted by such illnesses. 
 
It is impossible not to anticipate important results from the application of 
this inquiry to the different nerves of the animal system. But it is 
particularly with reference to nervous diseases that it will be most 
desirable to extend these researches. If one conviction impresses itself 
more firmly on the mind than another, it is that what we term functional 
diseases of the nerves are in reality owing to certain organic and physical 
changes in the tubular fibre, which it will be the province of the microscope 
to ascertain. 
 -Augustus Waller, 1850 (pp. 428-9) 
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Appendix I: Towards an Inhibitor of SARM1
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Jpred3 alignment and tertiary structure prediction of the SARM1 TIR 
domain
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Example of retro-inverso with a 3 amino acid peptide.  
Credit: http://en.wikipedia.org/wiki/Peptidomimetic 
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Appendix II: dSARM RNAi in Glia 
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Appendix III: Ablation of Tracheal Clones 
 
 
 
 
 
Wild-type tracheal clone ablation (arrows, top), and the same cells 24 
hours after ablation (bottom).  Cells are labelled with Btl-Gal4 driving myr-
tdTomato and GFP-nls. 
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Wild-type tracheal clones 24 hours post ablation (arrows).  Brackets 
highlight severed branches.  Cells are labelled with Btl-Gal4 driving myr-
tdTomato and GFP-nls.  Branch degeneration is only seen in 1 out of the 4 
clones at this time point.  
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